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A dysfunction of cortical and limbic GABAergic circuits has been postulated to contribute to multiple neurodevelopmental
disorders in humans, including schizophrenia, autism, and epilepsy. In the current paper, I summarize the characteristics that
underlie the great diversity of cortical GABAergic interneurons and explore how the multiple roles of these cells in developing and
mature circuits might contribute to the aforementioned disorders. Furthermore, I review the tightly controlled genetic cascades
that determine the fate of cortical interneurons and summarize how the dysfunction of genes important for the generation,
speciﬁcation, maturation, and function of cortical interneurons might contribute to these disorders.
1.Introduction
The exquisite complexity of cognitive functions stems
from tightly regulated interactions between distributed
cortical networks performing precise neural computations.
GABAergic inhibitory interneurons (INs), which represent
a minority of neocortical neurons (20% in rodents [1]),
play a crucial role in these cortical circuits. GABAergic
INs shape the responses of pyramidal cells to incoming
inputs, prevent runaway excitation, reﬁne cortical receptive
ﬁelds, and are involved in the timing and synchronisation
of population rhythms expressed as cortical oscillations
[2–9]. Consequently, disruption of cortical GABAergic IN
function has been linked to various neurodevelopmental
disorders, including epilepsy, mental retardation, autism,
and schizophrenia [10–15].
Cortical INs are diverse in terms of their anatomical lam-
inar distribution, histochemical marker expression, intrinsic
physiological properties, and connectivity (Figure 1)[ 5, 6,
9, 16–22]. This heterogeneity is characterized by the expres-
sion of speciﬁc combinations of ion channels, receptors,
and membrane cell adhesion molecules [7]. These speciﬁc
protein expression proﬁles are the result of tightly controlled
geneticpathwaysthatregulatecorticalINidentity[8,23–29].
Anomalies in these genetic pathways might therefore under-
lie some of the neurodevelopmental and neurocognitive
disorders seen in humans. In the current paper, I will give an
overviewofcorticalINdiversity,summarisethevariousroles
ofcorticalINsinneuronalcircuitdevelopmentandfunction,
review the genetic pathways involved in specifying cortical
GABAergic IN diversity, and explore the pathological corre-
latesofgeneticanomaliesleadingtointerneurondysfunction
in rodents and humans. As the current paper focuses on
neocortical INs, readers are directed to other sources for
a broader description of other GABAergic populations,
including those of the amygdala, striatum, hippocampus,
thalamus, and olfactory bulbs, which also participate in
the corticolimbic and corticosubcortical circuits involved in
cognition and emotional processing [7, 30–40].
1.1. Diversity of Cortical GABAergic Interneurons Subtypes
and Roles. Neocortical GABAergic INs are heterogeneous,
and diﬀerent subtypes of INs have diﬀerent spatial and tem-
p o r a lo r i g i n s .A sag r o u p ,n e o c o r t i c a lI N sa r ed e r i v e df r o m
transient ventral telencephalic structures referred to as the2 Neural Plasticity
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Figure 1: Interneuron diversity. Interneurons are diverse in terms of their histochemical proﬁle, morphology, physiological properties,
and connectivity. In this schematic representation, parvalbumin-positive (PV) interneurons (red) include basket cells forming perisomatic
contacts on adjacent pyramidal cells (dark blue), as well as chandelier cells that target the pyramidal cell axon initial segment. Somatostatin-
positive (SST) interneurons include Martinotti cells that contact pyramidal cell dendrites in layer I. Vasointestinal peptide (VIP) and
calretinin(CR)double-positivebituftedinterneuronstargetpyramidalcellsandotherinterneurons.Neurogliaformcells,markedwithreelin,
are the most abundant interneurons in layer I and provide tonic GABAergic inhibition via volume transmission of GABA.
ganglionic eminences [27, 29, 41–46]a sw e l la sf r o mt h e
preoptic area [47]. The medial ganglionic eminence (MGE)
produces approximately 70% of neocortical INs, including
the parvalbumin-positive (PV) fast-spiking interneurons
and the somatostatin-positive (SST) interneurons, which
represent 40% and 30% of all neocortical INs, respectively
[27, 46, 48]. By contrast, the caudal ganglionic eminence
(CGE) gives rise to the remaining 30% of neocortical INs,
a more heterogeneous group of cortical INs that share
the unique expression of 5HT3A ionotropic serotoninergic
receptors, rendering them highly responsive to the neuro-
modulatoryeﬀectsofserotonin[9,43,46,48,49].Amajority
of CGE-derived interneurons belong to either the reelin-
positive multipolar population (including the late-spiking
neurogliaform cells), the vasointestinal-peptide- (VIP-) pos-
itive bitufted population (including a calretinin- (CR)-
positive population), or the VIP-positive, calretinin-negative
bipolar population. Finally, the preoptic area contributes a
small portion of neocortical INs (<3%) that are not labelled
bytheusualinterneuronmarkersmentionedabove[47].The
lateralganglioniceminence(LGE)mainlyproducesolfactory
bulb and amygdalar INs, as well as striatal and nucleus
accumbens medium spiny neurons, but is generally thought
not to give rise to cortical INs [23, 33, 38, 41, 50, 51].
Diﬀerent subtypes of cortical INs are identiﬁed based on
their immunohistochemical, morphological, physiological,
and connectivity properties, and they mediate diﬀerent
f u n c t i o n si nm a t u r en e t w o r k sa sd e t a i l e db e l o w .
1.2. Parvalbumin-Positive Basket Cells. PV-positive interneu-
rons include the perisomatically targeting basket cells and
the less abundant axon-initial segment-targeting chandelier
cells. PV-positive basket cells can be further divided accord-
ing to various morphological characteristics, including
somatic diameter, ﬁring properties, and extent of dendritic
and axonal arborisation [5, 9, 52, 53]. As a group, PV-
positive basket cells display many characteristics which
render them one of the fastest and most reliable sources of
inhibition in the cortex. They exhibit low input resistance,
fast membrane kinetics, brief action potentials with large
afterhyperpolarisation, and minimal spike adaptation and
are able to sustain high frequency ﬁring rates [5, 18, 19,
21, 44, 52, 54]. These fast kinetics are partly due to their
expression of Kv3 voltage-gated potassium channels [52, 55–
59], which ensure quick repolarisation and termination of
action potentials. In addition, PV-positive fast-spiking cells
mediate fast reliable neurotransmission, as they rely mainly
on P/Q-type presynaptic Ca2+ channels for tight coupling
between action potentials and neurotransmitter release [60–
63]. Furthermore, these PV-positive basket cells might be
able to buﬀer calcium more eﬃciently, as they express high
levels of Ca2+-binding proteins, including parvalbumin and
calbindin. It is possible that this expression of Ca2+-binding
proteins renders these cells more resistant to Ca2+-induced
excitotoxicity in the face of high ﬁring rates.
PV-positive INs are the main inhibitory target of thalam-
ocortical projections in the cortex. In addition, PV-positive
basket cells form intricate nests of synaptic contacts on the
soma of adjacent pyramidal cells, giving them rapid control
over the excitability of their pyramidal cell targets. These
INs are therefore well positioned to provide strong and fast
feedforward inhibition to adjacent pyramidal cells, limitingNeural Plasticity 3
the time window for temporal summation of excitatory
inputs and spike generation within populations of pyramidal
cells.Thisfeaturesharpensthecorticalresponseandprevents
runawayexcitationfollowingthalamocorticalexcitation[64–
68].
In addition, PV-positive basket cells are highly inter-
connected with one another through both chemical and
electric synapses (gap junctions), creating a vast web of
synchronouslyactiveINs[69,70].Thisnetworkofinhibitory
INs triggers and maintains high-frequency gamma oscilla-
tions within ensembles of cortical pyramidal cells [69, 71–
77]. In support of this, the loss of connexin32, which forms
gap junction connections between PV-positive INs, results
in the partial loss of task-induced gamma oscillations [78].
Gamma oscillations are important for the maintenance of
attention, working memory, and the reﬁnement of executive
functions in humans and rodents [79–83]. Therefore, PV-
positive interneuron dysfunction has been postulated to
underlie the loss of gamma oscillations in schizophrenic
patients displaying working memory and executive function
abnormalities [14, 82, 84, 85].
1.3. Parvalbumin-Positive Chandelier Cells. Like PV-positive
basket cells, PV-positive chandelier cells display brief non-
adapting trains of action potentials upon stimulation and
are able to sustain high frequency ﬁring rates [17, 86, 87].
They are characterised morphologically by their cartridges
of vertically oriented candlestick-like axonal arbors [88–
90]) forming synapses on the axon initial segment (AIS) of
pyramidal cells [89, 91]. Chandelier cells are unusual among
interneurons in that their output has been postulated to be
excitatory rather than inhibitory. Indeed, the stimulation of
chandelier cells triggers depolarisations in target pyramidal
cells in the cortex and dentate gyrus [92–95]. This has been
attributed to the high concentration of chloride and elevated
GABAA reversal potential at the AIS, due to eﬃcient Cl−
import by the NKCC1 transporter in the absence of the
KCC2 transporter (see below) [92, 93]. However, it is still
unclear whether such depolarizing responses are obligatorily
excitatory [95]. Furthermore, in other circuits, such as
in the CA1 region of the hippocampus, chandelier cells
appear to trigger hyperpolarising responses [96]. Overall,
the net eﬀect of chandelier cells might be dependent on
the local state of network activity and on the particular ion
channel composition of local pyramidal cells in diﬀerent
brain regions. In vivo, chandelier cells might be involved
in the generation of speciﬁc oscillatory activities as they
ﬁre immediately before hippocampal pyramidal cells during
sharp-wave-associated ripples [97].
1.4.Somatostatin-Positive(SST)Interneurons. Somatostatin-
positive interneurons, including Martinotti cells and non-
Martinotti cells, are heterogeneous in terms of their
immunohistochemical proﬁle (variable colabelling with cal-
retinin and calbindin), morphology (multipolar, bipolar, or
unipolar), axonal projections (most target pyramidal cell
dendrites in layer I but some project locally within their
cortical layer), and intrinsic electrophysiological properties
[9, 45, 98–100]. A majority of SST interneurons (including
the Martinotti cells) share some physiological character-
istics, including a low spike threshold, prominent after-
hyperpolarisation, and spike rate adaptation. However, these
cells diﬀer in their spiking pattern at threshold (regular
versus bursting), especially when ﬁred from hyperpolarized
step currents [17, 98, 99]. In general, compared to fast-
spiking basket cells, SST-positive interneurons tend to be
more excitable: they display a lower spike threshold and have
a higher resting membrane potential [101]. One exception
to this rule is a population of non-Martinotti cells, which
have a high ﬁring threshold, higher ﬁring rate, shorter spike
half width, and lower input resistance [45, 99]. These cells
have been mostly described in layer 4 of the cortex and are
preferentiallylabelledintheX94GAD67-GFPtransgenicline
[9, 99].
SST-positive Martinotti cells are found across cortical
layers II-VI but are most abundant in cortical layer V. They
project vertically towards layer I where they contact pyra-
midal cell dendrites and extend multiple axonal collaterals
t o w a r d sa d j a c e n tc o r t i c a lc o l u m n s[ 19, 102, 103]. Martinotti
cells regulate pyramidal cell excitability by controlling the
dendritic summation and integration of synaptic inputs
and sharpening the coding of stimulus intensity [104].
Furthermore, as their connectivity is simultaneously diver-
gent, convergent, and recurrent, they mediate disynaptic
inhibition between interconnected pyramidal cells as well
as recurrent feedback inhibition onto presynaptic pyramidal
cells [105, 106]. They are therefore well suited to prevent
excessive and recurrent excitation within cortical networks.
Furthermore, they are increasingly recruited by sustained
stimulation, owing to the fact that the synapses that they
receive from pyramidal cells are in most cases facilitating
[101, 107]. This renders them good candidates to dampen
excitation during high activation states. Dysfunction of
somatostatin cells has therefore been postulated to underlie
some forms of experimental or poststatus epilepticus seizure
disorders [108].
Because of their expression of low-threshold voltage-
gated calcium channels and persistent sodium currents,
about 40% of SST cells display intrinsic bursting abilities and
might act as pacemaker cells, thereby triggering particular
cortical oscillations [224]. Indeed, SST-positive cells, which
are highly interconnected via gap junctions, tend to oscillate
spontaneously in the theta range (3–9Hz) when stimulated
electrically or with cholinergic agonists in vitro [101]. They
could therefore be involved in pacing cortical pyramidal cells
in the theta range.
1.5. Vasoactive Intestinal Peptide- (VIP-) Positive Interneu-
rons. CGE-derived interneurons tend to populate more
superﬁcial cortical layers than MGE-derived interneurons.
Approximately 40% of CGE INs express VIP, and these cells
tend to be enriched in layers II/III [19, 46, 48, 225, 226]. VIP-
positive INs are diverse morphologically, histochemically,
and physiologically [9]. The most abundant type are the
bitufted VIP+ INs that tend to colabel with CR [46, 48],
display an irregular-spiking ﬁring pattern near threshold
[18, 46, 48, 49, 227], and send a downward projecting axon
towards deeper cortical layers. The second most abundant4 Neural Plasticity
type is the VIP+, CR− bipolar cells, which display a fast
adapting ﬁring pattern [44, 46, 48, 227] and send extensively
branched projections both locally and towards deep cortical
layers. Due to their high input resistance, VIP INs tend to be
highly excitable [18, 46, 48]. They have been shown to target
pyramidal cell dendrites and somata [17], but some subsets
appear to target other interneurons more preferentially
[228–230]. The precise function of VIP interneurons in
cortical networks remains to be determined. However, their
physiological characteristics and diverse synaptic targets
render them well suited to rapidly modulate the interactions
between pyramidal cells and MGE-derived interneurons.
Furthermore, as they receive strong input from pyramidal
cellsinlayersII-III[231],whichalsoreceiveinputfrompyra-
midalcellsinotherfunctionallyconnectedcorticalareas,VIP
interneurons might be important in regulating cross-cortical
communication(i.e.,sensorimotormodulationwhereinputs
from the sensory cortex modulate the output of cortical
motoneurons).
1.6. Neurogliaform Cells. Neocortical neurogliaform cells
exist in all cortical layers but are the most abundant
GABAergic population in superﬁcial layer I [46, 48]. They
expr essr eelin(aswellasalphaactinin2intherat[103,232]),
butnotVIPorSST[9,46].Theyaremorphologicallydistinct
as they have multiple radially oriented dendrites extending
from a small round soma, as well as a ﬁnely branched
dense axonal plexus typically extending well beyond the
dendritic tree, giving them a spider web appearance [19,
233]. Neurogliaform cells display late-spiking ﬁring patterns
with spike accommodation during sustained depolarisations
[19, 44, 45, 48, 234]. They have been shown to elicit slow
long-lasting inhibitory events (IPSPs) in pyramidal cells and
other interneurons by activating both GABAA and GABAB
receptors after nonsynaptic volume release of GABA [233–
235]. Some of this tonic inhibition is thought to be mediated
through the activation of delta subunit-containing GABAA
receptors, which are modulated by neurosteroids [235]. This
eﬀect might underlie the antiepileptic eﬀect of steroids used
to treat pharmacoresistant epilepsies [236, 237]. Further-
more, neurogliaform cells are extensively interconnected by
electrical gap-junction synapses but also contact most other
interneurons subtypes via similar electrical synapses [238–
240]. They are therefore well suited to shape synchronous
cortical oscillations. Finally, some neurogliaform cells release
nitric oxide, a potent vasodilator, and may therefore play
a role in the neurovascular adjustment of blood ﬂow in
the face of cerebral hypoperfusion (i.e., strokes, shock, etc.)
[241, 242].
2. The Development of Cortical
InterneuronsDepends on Tightly
RegulatedGeneticCascades
Cortical interneurons originate in the ventricular zone of
the ventral telencephalic ganglionic eminences [41, 43,
243], migrate tangentially up to the cortex [218, 244], and
reach their ﬁnal destination after radial migration across
cortical layers. This is quite distinct from cortical pyramidal
cells, which originate from the cortical ventricular zone,
migrate radially, and reach their ﬁnal position after a brief
bout of tangential migration [42, 245]. The ganglionic
eminences are divided into three diﬀerent subdomains, the
medial (MGE), caudal (CGE), and lateral (LGE) ganglionic
eminences, which produce distinct subtypes of interneurons
in a temporally dynamic fashion [44–46, 246]. Cortical
interneuronsoriginatefromtheMGEandCGE[41,43,243],
as well as from the preoptic area [47]. Although this has
been debated, it is generally believed that the LGE does not
give rise to cortical interneurons, instead generating medium
spiny neurons of the striatum, nucleus accumbens, and
olfactory tubercules, as well as olfactory bulb and amygdalar
interneurons [23, 33, 38, 41, 50, 51].
The genetic code that governs the generation and
speciﬁcation of cortical interneurons has been extensively
studied over the last decade (Figure 2). The Dlx homeobox
genes, including Dlx1/2 and Dlx5/6, encode a family of
transcription factors crucial for the generation, speciﬁcation,
and migration of all interneurons. The proneural gene
mammalianachaete-scutehomolog1(Mash1),whichencodes
a basic helix-loop-helix transcription factor, is also crucial
for these processes. These genes are broadly expressed across
the subpallial subventricular zone (SVZ) of the ganglionic
eminences [218, 247–249]. In mice carrying compound Dlx1
and Dlx2 knock-out mutations, GABAergic interneurons fail
tomigrateoutoftheganglioniceminences,resultinginstrik-
ing reductions in cortical and olfactory bulb interneurons
as well as abnormal striatal diﬀerentiation [23, 219]. Similar
results are seen in mice lacking Mash1 [250]. Interestingly,
Dlx1/2 gene dosage appears to be important, as interneurons
in mice carrying a Dlx1−/−;D l x 2 +/− genotype displays
normal tangential migration to the cortical plate, but shows
alteredlaminarpositioningandsimpliﬁedmorphology(long
axons and dendrites with few branches) [220]. Furthermore,
Dlx1−/− mutants display selective defects in the dendritic
morphology of SST+/CR+ interneurons, with a progressive
loss of these interneurons in the postnatal brain, resulting in
spontaneous seizures [221].
The MGE and CGE give rise to distinct cortical
interneuronal populations [25, 41]. The MGE generates the
parvalbumin-positive (fast-spiking basket cells and chande-
lier cells) and somatostatin-positive interneurons (including
Martinotti cells) [8, 9, 22, 25, 41, 44, 45, 251]. The
speciﬁcation of these interneurons relies on the expression of
NK2 homeobox 1 (Nkx2-1)[ 22, 222]. The loss of Nkx2-1 as
interneuron progenitorsareexiting theirlastmitotic division
in the ganglionic ventricular zone leads to respeciﬁcation
of these cells into CGE-type interneurons (of all major
subtypes)andtheconsequentabsenceofcorticalPVandSST
interneurons [22]. Interestingly, PV interneurons originate
mainly from the ventral MGE whereas SST cells are preferen-
tiallyproducedbythedorsalMGE[251,252],aphenomenon
likely mediated by the combinatorial expression of particular
transcription factors within diﬀerent subdomains of the
MGE [252, 253], resulting in part from a gradient of SHH
expression [254]. Furthermore, a portion of the dorsal
MGE and the MGE-CGE sulcus region is delineated by theNeural Plasticity 5
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Figure 2: Genetic cascade governing cortical interneuron generation. Corticolimbic interneurons originate in the medial and caudal
ganglionic eminences (MGE and CGE). The homeobox transcription factors Dlx5/6, Dlx1/2 a n dt h ep r o n e u r a lg e n eMash1 (not shown)
are expressed throughout the ganglionic eminences and are required for the generation of all GABAergic interneurons. The MGE generates
parvalbumin-positive (PV) basket cells and chandelier cells, as well as somatostatin-positive (SST) cells (including Martinotti cells). These
rely on the sequential expression of Nkx2.1, Lhx6,a n dSox6 for proper speciﬁcation andmaturation(seetext).Thegenetic cascade governing
the speciﬁcation of CGE-derived interneurons has not been fully elucidated yet, but Nkx6.2 and Gsh2 are expressed in the CGE and might
be important players (see text).
expressionofthehomeodomaintranscriptionfactorNkx6-2,
which partially overlaps with Nkx2-1. This area gives rise
to the subgroup of somatostatin cells (about 30%) that
coexpress somatostatin and calretinin and display a delayed
nonfast spiking ﬁring pattern [251, 255].
As they leave the ventricular zone, MGE-derived in-
terneurons begin to express the transcription factor LIM
homeobox protein 6 (Lhx6), which is expressed into adult-
hood [26, 222, 251, 256, 257]. Lhx6 is required for proper
speciﬁcation and migration of MGE-derived interneurons,
and the loss of Lhx6 results in misspeciﬁed hippocampal and
cortical INs. These cells retain their GABAergic identity, but
they fail to express PV or SST and are mislocalised within
the neocortex [257]. Indeed, Lhx6 loss disrupts the correct
expression of downstream eﬀectors known to be important
for IN migration, including v-erb-a erythroblastic leukemia
viral oncogene homolog 4 (ErbB4), C-X-C chemokine receptor
type 4 (CXCR4)a n dtype 7 (CXCR7), and aristaless-related
homeobox (ARX)[ 26, 258].
Downstream of Lhx6 is SRY-box 6 (Sox6), another
transcription factor expressed by MGE-derived interneurons
as they initiate their tangential migration. Sox6 is required
for the proper laminar distribution and maturation of MGE-
derived interneurons [28]. Its loss results in mislocalised
MGE-derived INs that accumulate ectopically in layer I
and deep layer VI, failing to adequately populate cortical
layers II–V [28, 223]. Furthermore, these cells fail to express
their mature markers, leading to a striking loss of cortical
PV- and SST-expressing cells (PV being more severely
aﬀected). Although they remain correctly speciﬁed as MGE-
INs, as evidenced by their morphology, electrophysiological
properties, and expression of GABA, the resulting mutant
cells fail to acquire mature intrinsic properties. For instance,
PV-cells are unable to sustain the high frequency ﬁring rates
expected from these cells by P17-18 [28]. This results in
a severe developmental epileptic encephalopathy with early
lethality during the 3rd postnatal week [28].
As detailed above, the CGE produces a great variety
of cortical interneurons, which populate the more superﬁ-
cial cortical layers. CGE-derived INs include all VIP- and
reelin-positive cells, including the calretinin bipolar and
neurogliaform cells, as well as multiple smaller subgroups
of cortical interneurons, which are distinguishable by their
morphological and physiological properties [25, 43, 44, 46].
The master regulatory genes for CGE cell-fate determination
have yettobe fullydetermined. However,some transcription
factors are expressed in both the CGE and dorsal MGE,
including Nkx6-2 and CoupTF1/2, and might play a role in
the speciﬁcation of CGE interneurons [255].
3. GABAergic InterneuronsPlay Fundamental
Roles inDevelopingCircuits
GABA signalling is crucial during embryogenesis for both
neuralandnonneuralpopulationsofcells[259].Infact,early
GABAergic signalling has been shown to aﬀect neurogenesis,
diﬀerentiation, migration, and integration of developing
neurons into neuronal circuits [260, 261]. Indeed, GABAA
receptors are expressed early in newborn pyramidal neurons,
which receive GABAergic inputs long before forming exci-
tatory synapses [262, 263]. GABA is excitatory in immature6 Neural Plasticity
neurons due to the high level of NKCC1 expression. NKCC1
increases the intracellular concentration of Cl−, shifting the
GABA equilibrium potential (EGABA)t om o r ed e p o l a r i s e d
levels, thereby leading to an extrusion of negatively charged
chloride anions upon activation of GABAA receptors and
a depolarisation of the cell membrane [264]. With time,
the progressive expression of another chloride transporter,
KCC2, lowers the baseline intracellular concentration of
Cl− and underlies the developmental switch of EGABA in
favour of an inhibitory eﬀect of GABA in mature neurons
[265, 266].
This developmental switch is important in controlling
the migration, ﬁnal position, and morphological maturation
of interneurons. Tangentially migrating interneurons have
been shown to release GABA in a nonvesicular manner
[267]. GABA then acts synergistically with AMPA/NMDA
receptor-mediated currents to promote tangential migration
of interneurons as long as it is depolarising. However, the
gradual expression of KCC2 shifts the reversal potential of
GABA and the resulting hyperpolarisation acts as a stop
signal to arrest the migration of cortical interneurons [268].
Interestingly, interneurons derived from the MGE, which
reachtheirﬁnallayerearlierthanCGE-derivedinterneurons,
also appear to express KCC2 earlier than CGE cells born
simultaneously [246]. KCC2 might therefore regulate some
of the diﬀerences observed in the laminar distribution of
interneurons originating from diﬀerent sources.
Furthermore, GABA-mediated depolarisations have
recently been shown to promote excitatory synapse for-
mation by facilitating NMDA receptor activation in cortical
pyramidal neurons [269]. Blocking these GABA-mediated
depolarisations, by in utero knock-down of NKCC1 or with
the NKCC1 antagonist bumetanide, results in decreased
numbers of functional excitatory synapses [269]. These
manipulations also lead to altered cell morphologies,
including thinner apical dendrites, simpliﬁed dendritic
trees, and decreased dendritic spine densities [269]. These
detrimental eﬀects of bumetanide appear to be long-lasting,
as they persist in the adult cortex and are associated with
developmental delay and altered prepulse inhibition in adult
mice [270]. Premature overexpression of KCC2 leads to
similar dendritic anomalies in cortical pyramidal cells as
those reported after blocking NKCC1 [271].
In summary, GABA plays fundamental roles at diﬀer-
ent stages of neuronal development, aﬀecting migration,
maturation, and synapse formation of both pyramidal cells
and interneurons. Furthermore, the precise eﬀect of GABA
postsynaptically is dependent on the intracellular concen-
tration of chloride, which is developmentally regulated via
the expression of various chloride cotransporters and which
varies depending on the age of the cells.
4. Interneuronsand EarlyNetwork Activities
GABergic INs serve diverse functions in developing and
in mature networks. As detailed above, they provide local
circuit inhibition and participate in the genesis and organ-
isation of speciﬁc mature neocortical and limbic oscillations,
which in turn modify how local circuits respond to incoming
signals. In addition, GABAergic interneurons are critical for
the proper maturation and wiring of developing networks
[8, 272], as well as for the regulation of critical period
experience-dependent cortical plasticity [132, 273–276]. In
particular, they have been involved in the generation of some
of the early postnatal cortical and limbic oscillatory activities
appearing during the ﬁrst postnatal week in rodents. These
synchronised network activities are thought to be important
for the proper morphological maturation of excitatory
and inhibitory neurons, including for the development of
complex dendritic trees and synaptic contacts.
The ﬁrst postnatal activities recorded are the syn-
chronous plateau assemblies (SPAs), which are prolonged
gap-junction-mediated calcium plateaus appearing between
P0-P3 in the rat hippocampus [277] and neocortex [278].
The cellular substrates that drive these SPAs are still
unknown, but it is interesting to note that some subsets of
cortical interneurons are extensively interconnected through
gap junctions [69, 70, 101] and could contribute to the
generation of SPAs. In the cortex, SPAs progressively coexist
with cortical early network oscillations (cENOs) between
P0-P5. cENOs are infrequent (0.01Hz) synaptically driven
calcium events with slow kinetics that depend on glu-
tamatergic AMPA- and NMDA-mediated synaptic activity
and that cause sustained depolarisation of large groups of
neurons.
These early network activities are then replaced by
the giant depolarising potentials (GDPs) recorded in the
hippocampus [279] and neocortex [278]b e t w e e nP 6 - P 8 .
GDPs are much more frequent (mean 0.1Hz), consist of fast
calcium events, and are entirely dependent on GABAergic
synaptic activity (as they are blocked by the GABAA antag-
onist bicuculline). In the hippocampus, GDPs have been
shown to result from the spontaneous activity of a subset
of highly connected GABAergic neurons, the hub neurons,
that pace whole populations of pyramidal cells in a rhythmic
fashion [280]. These hub cells receive more excitatory inputs
(EPSPs), display a lower action potential threshold, and
have a wider axonal arborisation than neighbouring local
GABAergic interneurons [280]. These characteristics render
them particularly well suited to generate waves of activity
in wide sets of neurons upon stimulation by incoming
inputs. GDPs coincide with a phase of active synaptogenesis
within the developing neocortical and limbic circuits. It is
therefore likely that a selective dysfunction of GABAergic
interneurons in these early developmental steps might alter
the process of synapse formation, either by decreasing these
early network activities or by exerting more direct eﬀects on
the postsynaptic membrane.
In summary, interneurons participate in the genesis of
early network activities which provide critical input for the
normal maturation and plasticity of corticolimbic networks.
In the mature brain, they provide local circuit inhibition and
govern the onset and maintenance of some of the corticol-
imbic oscillations. These combined functions underlie the
extensive impact of interneuronopathies on neurodevelop-
ment and cognition.Neural Plasticity 7
5.Interneuronopathiesand
Neurodevelopmental Disorders
Interneuron anomalies have been suspected to underlie
a variety of neurodevelopmental disorders in humans,
including epilepsy, autism, and schizophrenia [14, 15]. This
hypothesis stemmed from the observation of decreased
GAD67 expression in postmortem brain tissue from aﬀected
individuals [110]. Later genetic studies also supported this
hypothesis as variants in the GAD67 promoter area were
discovered in patients with childhood-onset schizophrenia
[113] or bipolar disorder [281]. Interestingly, many other
genes linked to neuropsychiatric disease have since been
shown to be preferentially expressed in developing cortical
interneurons in mice [282]. It is therefore appealing to
consider the possibility that genetic anomalies known to
aﬀect the development or function of interneurons in
mice might be involved in neuropathologies in humans.
Although genetic anomalies may manifest diﬀerently in mice
and humans due to diﬀerences in expression patterns or
compensation by other genes across species, alterations in
highly conserved genetic pathways or disturbances in fun-
damental physiological processes might translate similarly in
humans and mice. Furthermore, a host of environmental
factors will likely modify the disease expression in these
highly heterogeneous and likely polygenic pathologies. An
exhaustive review of the genetic causes of schizophrenia,
autism, and epilepsy is beyond the scope of this paper,
but we will attempt to summarize some of the compelling
evidence pointing to the roles of GABAergic neurons in these
disorders.
5.1. Interneuron Development in Humans. Human GABAer-
gic interneurons appear to be highly diverse as initially
recognized by Ramon y Cajal [283, 284], with a similar
array of PV-positive basket cells, PV-positive chandelier cells,
SST-positive Martinotti cells, VIP-CR bitufted cells, VIP
bipolar cells, and neurogliaform cells as that described in
other species [284, 285]. However, the relative proportion
of these various populations varies across species [286]. The
superﬁcial cortical layers II-III are considerably larger in the
human cortex, presumably underlying some of the enhanced
intercortical connectivity mediating higher brain functions
in primates. Consequently, CR-positive double-bouquet INs
appear to be considerably more numerous in the human
cortex [284, 285]. Furthermore, although most cortical
GABAergic interneurons develop in the ventral ganglionic
eminences in humans, a proportion of cortical INs appear
to originate from the cortical ventricular zone [284, 287–
289]. Nonetheless, similarities do exist with regards to the
molecular pathways involved in cortical interneuron genesis
in humans and rodents, with preservation of some of the
same fundamental genes including Mash1, Dlx1/2, Nkx2-1,
and Lhx6 [288, 290–293].
5.2. Interneurons and Schizophrenia. Schizophrenia is a
chronic psychiatric condition that combines neurocognitive
dysfunctions (i.e., delusions, hallucinations, and disorgan-
isation of thought), negative symptoms (i.e., ﬂat aﬀect,
avolition, and alogia), and social or occupational deteri-
oration (i.e., altered social interactions, deterioration in
personal hygiene, and inability to self-sustain) [294]. This is
accompanied by more speciﬁc cognitive impairments such
as abnormalities in perception, inferential thinking, volition,
linguistic ﬂuency, attention, executive functions (planning),
and working memory [295, 296].
The involvement of interneurons in the pathophysi-
ology of schizophrenia was suggested when the number
of prefrontal cortical GAD67-expressing cells was found
to be decreased in autopsy specimens from schizophrenic
patients [109, 110]. There is no net loss of cortical PV-
positive interneurons or calretinin-positive interneurons in
schizophreniccortices,asthetotalnumberofcellsstainedfor
eithermarkerispreserved[111,112].However,thereappears
to be a selective downregulation of GAD67 in PV-positive
interneurons in schizophrenic brains [112]. Furthermore,
thelevelof parvalbumin expression in thesecellsis decreased
[112]. As both parvalbumin and GAD67 expression are
known to be regulated by cortical activity [297, 298], these
ﬁndings could reﬂect secondary changes in response to
altered levels of cortical activity in schizophrenic patients.
Indeed, two schizophrenia susceptibility genes encoding the
trophic factor neuregulin 1 (NRG1) and its receptor ErbB4
(ERB4)[ 117–121] have been shown to facilitate activity-
dependent GABA release from PV-positive basket cells in
the mouse prefrontal cortex [299]. Selective loss of ErbB4
in PV cells causes a disinhibition of prefrontal pyramidal
cells and results in a schizophrenia-like phenotype in mice
[126]. In addition, the speciﬁc expression of ErbB4 in PV
cells is required for neuregulin-1-dependent regulation of
hippocampal long-term potentiation [127], which is altered
in schizophrenic patients. Interestingly, hypostimulation of
PV-positive basket cells via selective ablation of the NR1
subunit of the NMDA receptors in these cells resulted
in schizophrenia-like behaviors (working memory deﬁcits,
impaired prepulse inhibition, locomotor hyperactivity, and
anxiety)anddecreasedPVandGAD67expressioninPVbas-
ket cells in a mouse model of schizophrenia [128]. Therefore,
hypofunction of prefrontal PV INs, either through a primary
dysfunction of these cells or a decreased excitatory drive to
these cells, appears to result in behavioural consequences in
mice, which recapitulate aspects of the phenotype observed
in schizophrenic patients.
Additionally, other genetic anomalies found in schizo-
phrenic patients that are predicted to aﬀect cortical matura-
tion more broadly appear to impact interneuron maturation
and GAD67 expression. For instance, brain-derived neu-
r o t r o p h i cf a c t o r( B D N F )i sn o r m a l l yr e l e a s e di na na c t i v i t y -
dependent fashion from pyramidal cells and was shown to
regulatethematurationofGABAergicINs[129].BothBDNF
and its receptor TrkB have been found to be downregulated
in the prefrontal cortex of schizophrenic patients [122–
124]. Knock-out mice for both BDNF and TrkB display
behavioral anomalies and a decrease in the synaptic expres-
sion of GAD67/GABA [130, 131]. Similarly, the neural
cell adhesion molecule NCAM, important for neuronal
morphological maturation and synapse formation, requires
the addition of a polysialic acid (PSA) moiety to function8 Neural Plasticity
properly. The activity-mediated expression of PSA has been
shown to regulate PV-positive basket cell maturation and
determine critical-period plasticity [132]. Interestingly, this
PSA-NCAM coupling has been reported to be decreased
in hippocampal specimens from schizophrenic patients
[125], which would suggest abnormalities in interneuron
maturation and cortical plasticity.
Another interesting hypothesis is that PV-positive chan-
delier cells might be aﬀected in schizophrenic brains. Indeed,
a speciﬁc loss of more than 40% of the axonal cartridges (the
GAT-1 positive axonal branches from chandelier cells which
contact the axon initial segments of pyramidal cells) has
been demonstrated in the prefrontal cortex of schizophrenic
patients[114,115].Thisisaccompaniedbyenhancedexpres-
sion of the alpha2 GABAA receptor subunit on the axon
initial segment of pyramidal cells, likely as a compensatory
mechanism for the decreased input from chandelier cells
[300]. However, since chandelier cells are possibly excitatory
[94, 95], the net eﬀect of these structural changes on local
cortical excitability is uncertain. More recently, the levels
of SST, NPY, and CCK were shown to be decreased in
a microarray analysis of prefrontal cortical samples from
schizophrenic patients [116]( Table 1). Furthermore, there
seems to be a speciﬁc decrease in SST-positive interneurons,
as shown by in situ hybridisation staining, in these samples
[116]. However, these results await replication.
Nonetheless, even if the numbers of various interneuron
subtypes are preserved and if the morphological structure of
these cells is intact in most cases, functional abnormalities in
theconnectivityofGABAergiccircuitslikelyplayaroleinthe
pathogenesis of psychiatric disorders. Modiﬁcations of the
speciﬁc GABAA receptor subunits expressed in the prefrontal
cortex of schizophrenic patients have been described [116,
301]. Furthermore, cortical prefrontal gamma oscillations
triggered by working memory tasks and selective attention in
humansandprimates[79–81]aredecreasedinschizophrenic
patients with working memory deﬁcits. These patients
display a loss of gamma oscillation power and gamma
oscillations are less tightly phase-locked to the task [82, 84,
85]. These changes might reﬂect functional alterations in the
PV-positive basket cells, which contribute to the generation
and regulation of the gamma oscillations that synchronise
assemblies of pyramidal cells involved in a speciﬁc task
[69, 72, 76–78, 83, 302]. In summary, multiple studies point
to putative anomalies, either structural or functional, in
PV-positive INs in the prefrontal cortex of schizophrenic
patients.
5.3. Interneurons and Autism. Autism is a neurodevelop-
mental disorder combining impairments in socialization,
communication, and restricted interests and/or stereotyped
behaviors [294]. Autistic traits can be found in a variety
of well-deﬁned neurogenetic syndromes, including tuberous
sclerosis [303, 304], fragile X syndrome [133, 134], and
Rett syndrome [294]. In addition, nonsyndromic autism
(re: without a clear underlying pathology, dysmorphic traits,
or structural brain anomalies) has been associated with a
variety of de novo copy number variants (CNVs) in large
genome-wide association studies [141, 305–308], a ﬁnding
which must be interpreted with caution [309]. However,
the discovery of point mutations in genes encoding various
synaptic scaﬀolding proteins in patients with nonsyndromic
autism has begun to shed light on the pathophysiology of
this disorder (recently reviewed in [309]). In particular, the
discovery of mutations in postsynaptic neuroligins (NRL4X,
NRL3)[ 135, 136], in other postsynaptic scaﬀolding proteins
(SHANK2, SHANK3)[ 137–140, 310], in the presynaptic
neurexins (NRXN1)[ 141, 142], and in fragile X mental
retardation protein (FMR1 gene) suggest that dysfunction in
the maintenance of excitatory synapses, synaptic plasticity,
and long-term depression participate in the neurobiology
of autism and that this might be rescued by metabotropic
glutamatergic antagonists [151–154, 156, 311, 312].
In parallel, a dysfunction in GABAergic signalling has
been postulated to contribute to the emergence of autistic
behaviours. In fact, epilepsy is a frequent comorbidity of
autism. Interictal epileptic activity is recorded on scalp EEG
in up to 85% of autistic children, although seizures occur in
only ∼30% of patients [313, 314]( Table 2). This, together
with the ﬁnding of decreased cortical GAD67/GAD65
expression in autistic patients’ brains [143], has suggested
that inhibitory dysfunction might play a role in subsets of
autistic patients. Furthermore, polymorphisms in the Dlx1/2
genes have been associated with an increased susceptibility
for autism [144] supporting the link between GABAergic
anomalies and autism. In addition, nonsyndromic autism
has been repeatedly associated with maternal chromosomal
duplications in the 15q11-13 region [145, 146], which
includes multiple genes encoding various GABAA receptor
subunits (GABRA5, GABRG3,a n dGABRB3). Interestingly,
MecP2, a transcription factor that broadly regulates gene
expression by binding methylated CPG islands and which
is responsible for the majority of cases of Rett syndrome
(see next section), also exerts epigenetic control over this
chromosomal region [157]. The loss of MecP2 results in dys-
regulation of multiple genes, including the downregulation
of GABRB3. Furthermore, the loss of MecP2 is particularly
detrimental to interneurons and a conditional MecP2 abla-
tion in GABAergic neurons in mice was recently shown to
recapitulatemostofthebehavioralanomaliesassociatedwith
Rett syndrome, including autistic-like behavior [158].
Finally, another well-characterised mouse model of
autism, the uPAR−/− mouse, displays a spatially selective
defect in interneuron migration, such that the frontoparietal
cortices of these mice show 50% less calbindin-positive
interneurons (with a near absence of PV cells) whereas
more caudal cortices are spared [11, 12]. These mice
display autistic-like behaviors with increased anxiety and
altered socialisation, as well as interictal epileptiform EEG
activity and an increased susceptibility to seizures [11, 12].
uPAR encodes an urokinase plasminogen activator which is
required for the proper processing of the hepatocyte growth
factor (HGF). In turn, HGF, through its receptor MET,
has been shown to be a critical motogen for interneuron
migration and is able to rescue the interneuron migration
defect and seizure susceptibility of uPAR−/− mice [159, 160].
Interestingly, polymorphisms in the MET promoter haveNeural Plasticity 9
Table 1: Findings in schizophrenic patients and correlations in mice models.
Findings References
Humans
GAD67
↓ GAD67 in prefrontal cortex Volk et al. [109]
Akbarian et al. [110]
Preserved # number of PV cells, cortex Woo et al. [111]
Hashimoto et al. [112]
↓ GAD67 level in PV cells, cortex Hashimoto et al. [112]
Association with polymorphisms in GAD67 promoter Addington et al. [113]
Chandelier Decrease in chandelier cells cartridges (GAT1+) in prefrontal cortex Woo et al. [114]
Volk et al. [115]
SST ↓ levels of SST in microarray analysis and ↓ number of SST cells, prefrontal cortex Hashimoto et al. [116]
NPY/CCK ↓ levels of NPY and CCK in microarray analysis Hashimoto et al. [116]
NRG1 Susceptibility locus in NRG1
Stefansson et al.
[117, 118]
Zhang et al. [119]
Yang et al. [120]
ERB4 Susceptibility locus in ERB4 Silberberg et al. [121]
BDNF/Trkb
Downregulation of BDNF in prefrontal cortex Weickert et al. [122]
Wong et al. [123]
Downregulation of BDNF and Trkb in prefrontal cortex Takahashi et al. [124]
PSA/NCAM ↓ PSA-NCAM complexes in hippocampus Barbeau et al. [125]
Gamma
Gamma oscillations are triggered by working memory tasks + selective attention Tallon-Baudry et al. [79]
Howard et al. [81]
Decreased power of cortical gamma oscillations and phase locking to memory task Spencer et al. [82, 84]
Cho et al. [85]
Mice
Erb4 Selective interneuron loss of Erb4: “schizophrenia-like behaviors” Wen et al. [126]
Erb4/Nrg1 Erb4 in PV cells is required for Nrg1-dependant regulation of LTP (hippocampus) Chen et al. [127]
NR1
Selective loss of the NMDAr NR1 subunit in PV cells: decreased excitatory input to
PV cells results in “schizophrenia-like behaviors” and ↓ expression of PV and
GAD67
Belforte et al. [128]
BDNF BDNF regulates activity-dependant maturation of PV cells
Bdnf−/− and Trkb−/−: ↓synaptic GAD67 and GABA and behavioral anomalies
Huang et al. [129]
Cotrufo et al. [130]
Hashimoto et al. [131]
PSA/NCAM Activity-mediated expression of PSA regulates PV cells maturation and visual
plasticity Di Cristo et al. [132]
Gamma
Gamma oscillations are triggered by stimulating PV cells: enhanced performance Cardin et al. [77]
Sohal et al. [83]
Gamma oscillations depend on PV cells-mediated fast-synaptic inhibition Bartos et al. [72]
recently been described to confer an increased susceptibility
to autism and this gene is included in one of the genomic
sequences linked to autism susceptibility (7q31) [149, 150].
Autism is a complex disorder and alterations in other
GABAergic circuits, including the striatocortical circuits,
likely contribute to this behavioural phenotype. Indeed, an
interneuron-selective ablation of MET results in decreased
cortical PV cells, but massively increased dorsal striatal PV
interneurons, leading to a disruption in striatal-mediated
procedural and reversal learning [161]. Nonetheless, cortical
and hippocampal GABAergic deﬁcits certainly play a role in
some of the cognitive-behavioral manifestations of autism,
as well as in the associated susceptibility to seizures.
5.4. Interneurons and Epilepsy. Perhaps one of the most
intuitive consequences of interneuron dysfunction is the
development of epilepsy. Multiple mouse models carrying
interneuronopathies have been shown to develop seizures
[22, 28, 57, 63, 206, 207, 221]. In parallel, various reports
point to probable GABAergic interneuron dysfunction in10 Neural Plasticity
Table 2: Findings in autistic children and correlations in mice models.
Findings References
Humans
FMR1 Patients with fragile X syndrome often display autistic traits Levitas et al. [133]
Brown et al. [134]
NRL4X/NRL3 Point mutations in NRL4X and NRL3 associated with X-linked autism Jamain et al. [135]
Point mutations in NRL4X in nonsyndromic autism Laumonnier et al.
[136]
SHANK3 Mutations in SHANK3 in nonsyndromic autism
Durand et al. [137]
Gauthier et al. [138]
Moessner et al. [139]
SHANK2 Mutations in SHANK2 in nonsyndromic autism Berkel et al. [140]
NRXN1 Mutations in NRXN1 nonsyndromic autism Szatmari et al. [141]
Kim et al. [142]
GAD65/67 ↓ levels of GAD65/67 in cortex Fatemi et al. [143]
Dlx1/2 Polymorphisms in Dlx1/2 with increased susceptibility to autism Liu et al. [144]
15q11-13 Maternal duplications in 15q11-13 in nonsyndromic autism Baker et al. [145]
including GABRA5, GABRG3, GABRB3 (GABAAR subunits) Hogart et al. [146]
MECP2 Mutations in MECP2 explain the majority of Rett syndrome. Amir et al. [147]
Patients display autistic behaviors. Buyse et al. [148]
MET Polymorphisms in MET promoter associated with autism Jackson et al. [149]
Susceptibility locus for autism at 7q31 includes MET gene. Campbell et al. [150]
Mice
Fmr1 Fmr1 k/o: behavioral anomalies improve with glutamatergic antagonists Dolen et al. [151]
Bear et al. [152, 153]
Neuroligins/
neurexins
NRL1/2 expression in nonneuronal cells trigger synapse formation in presynaptic
cells Scheiﬀele et al. [154]
NL-1 overexpression in hippocampal neurons promotes assembly of excitatory and
inhibitory synapses and knock-down results in loss of inhibitory > excitatory
synapses
Chih [155]
Presynaptic β-neurexin induces GABA and glutamate synapse diﬀerentiation in
postcell Graf et al. [156]
NRL1,3,4 localise at glutamatergic synapses, NRL2 at both excitatory and inhibitory Graf et al. [156]
MecP2 Binds methylated CPG islands and exerts epigenetic control of UBE3A and GABR3 Samaco et al. [157]
Interneuron selective loss of MecP2 recapitulates the Rett-like behavioral aN in
mice Chao et al. [158]
uPAR, HGF,
MET
uPAR−/− displays 50% loss of IN in cortex and seizure susceptibility Powell et al. [11]
uPAR is required for the processing of HGF (an interneuron motogen), Powell et al. [159]
HGF, through its receptor MET, can rescue the phenotype of uPAR−/− mice Bae et al. [160]
Interneuron selective MET ablation: ↓ PV cortex, ↑ striatal PV cells, disrupts
reversal learning Martins et al. [161]
developmental and symptomatic (posttraumatic or poststa-
tus epilepticus) epileptic disorders in humans [315–318]. In
most situations, early developmental interneuron anomalies
might contribute to seizure disorders both by altering the
normal development of cortical circuits, as detailed above,
and by failing to provide the acute inhibition required to
control excessive excitation in the mature network. Paradox-
ically, in a state of chronic excitation, INs have been shown
to contribute actively to ictogenesis when GABA becomes
depolarizing due to the failure of chloride extrusion from
damaged neurons [319, 320]. Therefore, both a primary
dysfunctionofGABAergicinhibitorytransmissionandasec-
ondary switch to excitatory GABAergic transmission could
contributetothepathogenesisofepilepsy.Understandingthe
molecular mechanisms governing interneuron development,
maturation, and normal function would therefore be very
informative in our quest to comprehend human epileptic
disorders.
Epilepsy is a heterogeneous disorder, and most cases
are symptomatic of focal or widespread CNS lesions (e.g.,
malformations,tumors,infections, trauma,strokes,hypoxia,
etc.). INs dysfunctions might contribute to seizure disordersNeural Plasticity 11
Table 3: Selected examples of genes causing epilepsy in humans and interneuron dysfunctions in mice.
Findings References
Humans
SCN1A
SCN1A mutations explain the majority of Dravet syndrome
Claes et al. [162]; Ohmori et al. [163]
Sugawara et al. [164]; Orrico et al. [165]
Escayg and Goldin et al. [166]
SCN1A mutations display phenotypic heterogeneity: GEFS, febrile
seizures, cognitive impairment
Escayg et al. [167, 168]
Fujiwara et al. [169]; Osaka et al. [170]
Zucca et al. [171]; Orrico et al. [165]
Variants in other channels modify the phenotype of SCN1A: SCN8A Martin et al. [172]
CACNB4 Ohmori et al. [173]
SCN1B SCN1B mutations cause GEFS Wallace et al. [174]
ARX ARX mutations cause various phenotypes including infantile
spasms Shoubridge et al. [175]
CDKL5 CDKL5 mutations cause early epileptic encephalopathies
Kalscheuer et al. [176]; Weaving et al. 2004
[177]
Scala et al. [178]; Archer et al. [179]
Cordova-Fletes et al. [180]; Mei et al. [181]
Melani et al. [182]
MECP2 MECP2 mutations explain most cases of Rett syndrome. These
patients often display seizures. Amir et al. [147]; Buyse et al. [148]
GABRG2
Mutations in the gamma2 subunit of the GABAAR cause childhood
absence epilepsy ± febrile seizure Wallace et al. [174]; Kananura et al. [183]
Truncation of GABRG2 causes generalised epilepsy with febrile
seizure (GEFS) Harkin et al. [184]
GABRA1
Mutations in the alpha1 subunit of the GABAAR cause juvenile
myoclonic epilepsy Cossette et al. [185]
Mutations in the alpha1 subunit of the GABAAR can also cause
childhood absence epilepsy Maljevic et al. [186]
CACNA1A Polymorphisms associated with generalised epilepsy syndromes Chioza et al. [187]
Mutations in CACNA1A can cause ataxia with generalized seizures Jouvenceau et al. [188]; Imbrici et al. [189]
CACNB4 Mutations in CACNB4 cause episodic ataxia with generalized
seizures Escayg et al. [190]
CACNA1H Mutations in T-type calcium channel Cav3.2 cause childhood
absence epilepsy Khosravani et al. [191]
Nkx2.1
Nkx2.1 haploinsuﬃciency leads to the “brain-lung-thyroid
syndrome” Carre et al. [192]
variable phenotype: severe respiratory distress at birth,
mild-moderate hypothyroidism, chorea Guillot et al. [193]
Some patients present benign hereditary chorea, occasionally with
cognitive impairment and seizures Kleiner-Fisman et al. [194, 195]
Dlx5/6 Dlx5/6 mutations result in craniofacial and limb anomalies:
ectodermal dysplasia Morasso et al. [196]; Lo Lacono et al. [197]
Sox 6 1 patient described with heterozygote Sox6 mutation:
craniosynostosis and facial dysmorphisms. Tagariello et al. [198]12 Neural Plasticity
Table 3: Continued.
Findings References
Mice
Scn1a
Scn1a (Nav1.1) expressed in most neuronal populations Yu et al. [199]
Scn1a+/−and Scn1a−/−mice develop spontaneous seizures and die
prematurely Yu et al. [199]
↓ sodium currents are speciﬁc to GABAergic interneurons in
Scn1a+/− and Scn1a−/− Yu et al. [199]
Selective loss of Scn1a in interneurons recapitulates seizure disorder Martin et al. [200]
Arx
Role in neuronal proliferation and migration Fricourt et al. [201, 202]
Speciﬁc requirement of Arx for interneuron migration Friocourt and Parnavelas [203]; Poirier et
al. [204]
Arx is a downstream target of Dlx1 Colasante et al. [205]
Arx(GCG)10+7 mice display seizures including spasms and ↓ no. of
CB and NPY interneurons Price et al. [206]
Selective loss of Arx in interneurons recapitulates the seizure
disorder Marsh et al. [207]
Cdkl5 Cdkl5 is coexpressed with Mecp2 in cortical neurons and can
phosphorylate Mecp2 Mari et al. [208], Bertani et al. [209]
MecP2 Mecp2 broadly represses gene expression by binding methylated
CPG islands Nan et al. [210, 211]
Cacna1a
Cacna1atg/tg tottering mutant displays ataxia and absence seizures Noebels et al. [212]; Fletcher et al. [213]
Gain of thalamic T-type currents cause enhanced rebound bursting
of TC cells in Cacna1atg/tg,C a c n a 1 a ln/ln Zhang et al. [214]; Tsakiridou et al. [215]
Interneuron selective ablation of Cacna1a leads to multiple types of
generalised seizures incl. absences Rossignol et al. [63]( a b s t r a c t )
Cacnb4
Cacnb4lh/lh loss-of-function mutants display spontaneous absence
seizures and ataxia Burgess et al. [216]
Thalamic tonic GABAA currents enhance rebound bursting of TC
cells in Cacnb4lh/lh Cope et al. [217]
Dlx1/2
Dlx1−/−Dlx2−/− mice die perinatally and display a failure of IN
migration to cortex and olfactory bulb
Anderson et al. [23, 218]; Bulfone et al.
[219]
Dlx1−/−Dlx2+/− abnormal laminar distribution of IN and simpliﬁed
morphology Cobos et al. [220]
Dlx1−/− morphological defect and postnatal loss of SST+/CR+
interneurons: spontaneous seizures Cobos et al. [221]
Nkx2.1
Nkx2.1−/− die perinatally. Nkx2.1 is required for MGE interneuron
generation. Sussel et al. [222]
Interneuron speciﬁc removal of Nkx2.1 results in misspeciﬁcation of
MGE cells into CGE cells, and seizures Butt et al. [22]
Sox6
Sox6−/− dies perinatally of craniofacial anomalies
Conditional loss of Sox6 in interneurons results in
misplaced/ectopic and immature basket cells (loss PV) Batista-Brito et al. [28]; Azim et al. [223]
Conditional loss of Sox6 in interneurons results in a severe epileptic
encephalopathy Batista-Brito et al. [28]
following such insults, as suggested by the ﬁnding of limbic
interneuronal loss after brain trauma or prolonged seizures
[321–324]. Hippocampal somatostatin-positive interneu-
rons appear to be particularly sensitive to seizure-induced
damage as demonstrated in animal models of drug-induced
epilepsy [13, 108, 324, 325], as well as in patients with
chronic temporal lobe epilepsy [326]. This might point
to a more selective vulnerability of this cell type which
could be amendable to neuroprotective therapies. A loss of
hippocampal PV cells [327] and alterations in the axonalNeural Plasticity 13
projections of PV-positive chandelier cells have also been
reported in patients with chronic epilepsy [316, 325, 328,
329]. Although it is not clear if these changes are the cause
or the consequence of repeated seizures [330, 331], they
probably contribute to the chronicity of the disease.
5.5. Interneurons in Genetic Developmental Epilepsies. Per-
haps most interestingly, GABAergic interneuron dysfunction
might contribute to a subset of genetic developmental
epilepsies. In those cryptogenic epilepsies where no apparent
etiology is found on examination or imaging (re: no dys-
morphic traits or neurocutaneous stigma and normal brain
CT/MRI), but where patients present clear neurological
dysfunction as episodic seizures with or without interictal
cognitive impairment, an underlying circuit dysfunction is
postulated. These patients with severe developmental epilep-
sies (i.e., Ohtahara syndrome, West syndrome, Lennox-
Gastaut syndrome, Dravet syndrome, etc.) are rarely amend-
able to surgical interventions, and only few reports of
neuropathological examination of surgical or postmortem
specimens are available. In most cases of West syndrome,
the neuropathological evaluation reveals either focal cortical
malformations or diﬀuse brain damage [332–335]b u ti t
i sf o u n dt ob e“ n o r m a l ”i nu pt o4 5 %o fc a s e s[ 336].
Nonetheless, functional inhibitory defects with disrupted
GABAARfunctionorimmaturepatternsofGABAARsubunit
expressionhavebeendemonstratedinsomecasesofinfantile
spasms [318, 337]. Such inhibitory defects might arise as a
consequence of genetic mutations that disrupt genes critical
for proper interneuron generation or function. For instance,
mutations in the alpha1 subunit of the voltage-gated sodium
channel NaV 1.1 (SCN1A), the aristaless-related homeobox
transcription factor (ARX), the cyclin-dependent kinase-like 5
(CDKL5), various GABAA receptor subunits and in the alpha
1 subunit of the voltage-dependent P/Q-type Ca2+ channel
(CACNA1A)havebeendescribedinpatientswithavarietyof
epilepticdisordersandsimilarmutationshavebeenshownto
impair GABAergic signalling in rodents (Table 3).
5.5.1. SCN1A. Mutations in SCN1A, which encodes the
neuronal voltage-gated sodium channel Nav1.1, have been
found to underlie a majority (75–85%) of cases of severe
myoclonicepilepsyofinfancy(Dravetsyndrome)[162–166].
Interestingly, SCN1A mutations have also been found to
causegeneralisedepilepsywithfebrileseizures(GEFS)aswell
asavarietyofdisorderswithneurocognitiveimpairmentand
variable seizure susceptibility [165, 167–171]. This extended
phenotypic variability stems both from the nature of the
mutations (nonsense mutations cause Dravet syndrome
whereas missense mutations tend to cause diﬀerent pheno-
types depending on their location [166, 338–340]) and from
the coexistence of genetic modiﬁers in other genes [172,
173]. Although Nav1.1 channels are found in most neuronal
populations in the rodent brain, their loss was found to
result in a more selective impairment of interneuronal
transmission in mice [199, 200]. Nav1.1 channels tend to
cluster predominantly at the level of the axon initial segment
of PV-positive interneurons [341], and their loss results in
failure of PV cells to maintain high frequency ﬁring rates
[341]. By contrast, pyramidal cell transmission is relatively
well preserved in Nav1.1 mutants, presumably though
compensation by other channels. Therefore, dysfunctions of
INs might contribute signiﬁcantly to the onset of epilepsy in
Scn1a mutants.
5.5.2. ARX. In a similar fashion, mutations in the ARX
gene are associated with a variety of neurological syn-
dromes that combine epilepsy and various degrees of
cognitive disabilities. The spectrum of phenotypes associ-
ated with ARX mutations extends from severe X-linked
lissencephalywithambiguousgenitaliaandseveremyoclonic
encephalopathies (Ohtahara syndrome, West syndrome), to
isolated nonsyndromic mental retardation [175]. The ARX
gene is necessary for proper neural proliferation, migration,
and diﬀerentiation [201–203, 342]. In particular, ARX was
shown to be essential for proper migration and laminar
positioning of interneurons [203, 204], partly because it
is a direct downstream target of Dlx1 [205]. Interestingly,
ARX knock-in mice carrying trinucleotide repeat insertion
mutationsrecapitulatingmutationsfoundinIScases,display
decreased numbers of telencephalic NPY+ and calbindin+
interneurons, and present an epileptic phenotype with early
epileptic spasms [206]. Furthermore, a conditional deletion
of ARX in GABAergic interneurons leads to a similar
loss of interneuron migration and is suﬃcient to cause a
developmental epileptic phenotype including brief spasm-
like seizures [207]. This supports the hypothesis that even
if ARX mutations might have broader consequences for
cortical development, the speciﬁc eﬀect on IN migration is
fundamental to the development of epilepsy.
5.5.3. CDKL5/MECP2. Other patients with early epileptic
encephalopathies have been found to carry mutations in
CDKL5 [176–182], a protein kinase highly expressed in
developing and mature neurons [343]. Interestingly, CDKL5
can directly bind and phosphorylate MecP2 and is coex-
pressed with MecP2 in cortical neurons [208, 209]. In
turn, MecP2 is a transcription factor that broadly represses
gene expression by binding methylated CPG islands [210,
211] and is therefore involved in the epigenetic control of
gene expression. MECP2 mutations explain a majority of
cases of Rett syndrome [147, 148], a neurodevelopmental
disorder manifested by progressive microcephaly, develop-
mental regression, stereotypies, and epilepsy. Interestingly,
aninterneuronselectiveablationofMecP2recapitulatesmost
of the neurological and behavioral consequences of MecP2
knock-out mutations in mice [158]. Since MecP2 is a direct
downstream target of CDKL5, it is possible that interneuron
dysfunction also contributes to the cognitive and epileptic
p h e n o t y p es e e ni nb o t hCDKL5 and MecP2 mutants.
5.6.Voltage-GatedCa2+ Channels. Finally,patientswithidio-
pathic generalized epilepsy syndromes (IGE) have been
shown to carry mutations in various GABAA receptor
subunits [174, 183–186, 344], as well as mutations or
polymorphisms in multiple subunits of voltage-gated cal-
cium channels, including the CACNA1A, CACNB4,a n d
CACNA1H genes [187–191, 345]. These patients present14 Neural Plasticity
various combinations of myoclonus, generalised tonic-
clonic “grand-mal” seizures, and absence seizures “petit-
mal.” Mutant mice carrying loss-of-function mutations in
Cacna1a or Cacnb4 display similar generalised spike-wave
absence seizures and have been instrumental in advancing
our understanding of generalised epilepsies [212, 213, 216,
346]. In these models, an enhanced thalamocortical rebound
bursting due to a gain in low-voltage activated Ca2+ currents
and excessive thalamic GABAA signalling have been shown
to result in hypersynchronisation of the thalamocortical cir-
cuitry and absence seizures [214, 215, 217, 347]. In addition,
we recently demonstrated that selective loss of Cacna1a from
cortical and limbic MGE-derived interneurons in mice is
suﬃcient to create a severe epileptic encephalopathy with
multiple types of generalised seizures [63]. We showed that
Cacna1a loss resulted in unreliable neurotransmission from
PV-positive interneurons. Furthermore, we demonstrated
that concurrent loss of Cacna1a from both MGE-derived
interneurons and cortical pyramidal cells results in a milder
epileptic phenotype characterised by absence seizures [63].
These ﬁndings suggest that, in some cases, alterations in
MGE-derived interneuron function might lead to a variety
of generalised seizures and that the severity of the phenotype
can be modulated by the involvement of other neuronal
populations. Concurrent with these observations, various
mouse models with either misspeciﬁed or immature MGE-
derived interneurons have also been shown to develop
severe epilepsies. For instance, Nkx2-1−/− and Sox6−/− null
mutants die embryonically or perinatally due to a variety
of craniofacial and lung anomalies [222, 348]. However,
conditional mutants lacking either Nkx2-1 or Sox6 in an
MGE-speciﬁc manner develop generalised seizures during
the 2nd or 3rd postnatal week, leading to early lethality
[22, 28]. In a similar fashion, Dlx1−/− mice also develop
spontaneous seizures [221].
One of the limitations in extending some of the exper-
imental ﬁndings from genetic models of interneuronopathy
to human diseases is that most of the transcription factors
important for interneuron development and speciﬁcation
are also involved in speciﬁcation of other organs (bone,
skin, cartilage, lung, and thyroid). Mutations in these genes
therefore cause multisystemic disorders in which neurolog-
ical involvement is often overlooked. For instance, human
heterozygote mutations in Nkx2-1 have been described in a
variety of clinical disorders aﬀecting the thyroid, the lungs,
and the brain, the so-called “brain-lung-thyroid” syndrome
[192]. In some cases, truncating mutations result in severe
respiratory failure at birth, due to the lack of surfactant pro-
teins, with mild congenital hypothyroidism and neurocogni-
tive anomalies [193]. In other cases, Nkx2-1 mutations have
been described in patients with benign hereditary chorea, a
movementdisorderoccasionallyaccompaniedbyintellectual
impairment and seizures [194, 195]. In a similar fashion,
heterozygous mutations in Dlx5/6 genes cause craniofacial
and limb anomalies (ectodermal dysplasias) [196, 197]. Sox6
is known to be important for proper cartilage formation
[348–350], and one child with craniosynostosis (premature
fusion of the cranial sutures) and facial dysmorphisms has
been shown to carry a heterozygous mutation in SOX6
[198]. However, even when direct inferences cannot be made
between mouse mutants and human patients, the study of
these animal models is instrumental in clarifying the role
of speciﬁc interneuron populations in preventing various
types of seizures and is critical to our understanding of
epileptogenesis.
6. Conclusions andFuturePerspectives
In summary, GABAergic INs include diverse neuronal pop-
ulations which present signiﬁcant heterogeneity in terms of
their biochemical, morphological, and physiological proper-
ties. The fate of these INs is governed by tightly regulated
genetic cascades. Disruption of these genetic programs, or
of genes important for the proper speciﬁcation, migration,
maturation, and/or function of these cells, leads to a variety
of cognitive, behavioural, and neurological consequences
including autistic behaviors and epilepsy in rodents and
humans. For this reason, furthering our understanding of
interneuron development across mammalian species might
become the cornerstone for the subsequent development
of improved diagnostic approaches, and hopefully new
therapeutic strategies, for patients with a variety of neu-
rodevelopmental disorders. A fascinating example of this
is the development of stem cell transplantation in the
treatment of epileptic disorders in rodents [351, 352]. Other
such innovative therapeutic approaches will likely emerge as
the exquisite complexity of cortical interneurons diversity
unravels.
Acknowledgments
The author is grateful to J. Hjerling-Leﬄer, J. Close, and
S. Rossignol for their enlightening input in reviewing this
paper.TheauthoralsowishestothanktheFondderecherche
en sant´ ed uQ u ´ ebec (FRSQ), the U. de Montr´ eal, and
the Centre de recherche de l’Hˆ opital Ste-Justine for their
support.
References
[1] N. Tamamaki, Y. Yanagawa, R. Tomioka, J. I. Miyazaki, K.
Obata, and T. Kaneko, “Green ﬂuorescent protein expres-
sion and colocalization with calretinin, parvalbumin, and
somatostatin in the GAD67-GFP knock-in mouse,” Journal
of Comparative Neurology, vol. 467, no. 1, pp. 60–79, 2003.
[2] C. J. McBain and A. Fisahn, “Interneurons unbound,” Nature
Reviews Neuroscience, vol. 2, no. 1, pp. 11–23, 2001.
[3] F. Pouille and M. Scanziani, “Enforcement of temporal
ﬁdelity in pyramidal cells by somatic feed-forward inhibi-
tion,” Science, vol. 293, no. 5532, pp. 1159–1163, 2001.
[4] M. Wehr and A. M. Zador, “Balanced inhibition underlies
tuningandsharpensspiketiminginauditorycortex,”Nature,
vol. 426, no. 6965, pp. 442–446, 2003.
[5] H. Markram, M. Toledo-Rodriguez, Y. Wang, A. Gupta, G.
Silberberg, and C. Wu, “Interneurons of the neocortical
inhibitory system,” Nature Reviews Neuroscience, vol. 5, no.
10, pp. 793–807, 2004.Neural Plasticity 15
[6] P. Somogyi and T. Klausberger, “Deﬁned types of cortical
interneurone structure space and spike timing in the hip-
pocampus,” Journal of Physiology, vol. 562, no. 1, pp. 9–26,
2005.
[7] T. Klausberger and P. Somogyi, “Neuronal diversity and
temporal dynamics: the unity of hippocampal circuit oper-
ations,” Science, vol. 321, no. 5885, pp. 53–57, 2008.
[ 8 ] R .Ba ti s t a - B ri t oa n dG .F i s h e ll ,“ C h a p t e r3t h ed ev e l o p m e n t a l
integration of cortical interneurons into a functional net-
work,” Current Topics in Developmental Biology, vol. 87, pp.
81–118, 2009.
[9] B. Rudy, G. Fishell, S. Lee, and J. Hjerling-Leﬄer, “Three
groups of interneurons account for nearly 100% of neocor-
tical GABAergic neurons,” Developmental Neurobiology, vol.
71, no. 1, pp. 45–61, 2010.
[10] J. L. Noebels, “The biology of epilepsy genes,” Annual Review
of Neuroscience, vol. 26, pp. 599–625, 2003.
[11] E. M. Powell, D. B. Campbell, G. D. Stanwood, C. Davis,
J. L. Noebels, and P. Levitt, “Genetic disruption of cortical
interneuron development causes region- and GABA cell
type-speciﬁc deﬁcits, epilepsy, and behavioral dysfunction,”
The Journal of Neuroscience, vol. 23, no. 2, pp. 622–631, 2003.
[12] P. Levitt, K. L. Eagleson, and E. M. Powell, “Regulation of
neocortical interneuron development and the implications
for neurodevelopmental disorders,” Trends in Neurosciences,
vol. 27, no. 7, pp. 400–406, 2004.
[13] R. Cossart, C. Bernard, and Y. Ben-Ari, “Multiple facets of
GABAergic neurons and synapses: multiple fates of GABA
signalling in epilepsies,” Trends in Neurosciences, vol. 28, no.
2, pp. 108–115, 2005.
[14] D. A. Lewis, T. Hashimoto, and D. W. Volk, “Cortical
inhibitory neurons and schizophrenia,” Nature Reviews Neu-
roscience, vol. 6, no. 4, pp. 312–324, 2005.
[15] S. Akbarian and H. S. Huang, “Molecular and cellular mech-
anisms of altered GAD1/GAD67 expression in schizophrenia
and related disorders,” Brain Research Reviews, vol. 52, no. 2,
pp. 293–304, 2006.
[16] J. DeFelipe, “Neocortical neuronal diversity: chemical het-
erogeneity revealed by colocalization studies of classic neuro-
transmitters, neuropeptides, calcium-binding proteins, and
cellsurfacemolecules,”Cerebral Cortex,vol.3,no.4,pp.273–
289, 1993.
[17] Y. Kawaguchi and Y. Kubota, “Physiological and morpho-
logical identiﬁcation of somatostatin-or vasoactive intestinal
polypeptide-containingcellsamongGABAergiccellsubtypes
in rat frontal cortex,” The Journal of Neuroscience, vol. 16, no.
8, pp. 2701–2715, 1996.
[18] B. Cauli, E. Audinat, B. Lambolez et al., “Molecular and
physiological diversity of cortical nonpyramidal cells,” The
Journal of Neuroscience, vol. 17, no. 10, pp. 3894–3906, 1997.
[19] Y. Kawaguchi and Y. Kubota, “GABAergic cell subtypes and
their synaptic connections in rat frontal cortex,” Cerebral
Cortex, vol. 7, no. 6, pp. 476–486, 1997.
[20] A. Gupta, Y. Wang, and H. Markram, “Organizing principles
foradiversityofGABAergicinterneuronsandsynapsesinthe
neocortex,” Science, vol. 287, no. 5451, pp. 273–278, 2000.
[21] G. A. Ascoli, L. Alonso-Nanclares, S. A. Anderson et al.,
“Petilla terminology: nomenclature of features of GABAergic
interneurons of the cerebral cortex,” Nature Reviews Neuro-
science, vol. 9, no. 7, pp. 557–568, 2008.
[ 2 2 ]S .J .B .B u t t ,V .H .S o u s a ,M .V .F u c c i l l oe ta l . ,“ T h e
requirement of Nkx2-1 in the temporal speciﬁcation of
cortical interneuron subtypes,” Neuron,v o l .5 9 ,n o .5 ,p p .
722–732, 2008.
[23] S. A. Anderson, M. Qiu, A. Bulfone et al., “Mutations of
the homeobox genes Dlx-1 and Dlx-2 disrupt the striatal
subventricular zone and diﬀe r e n t i a t i o no fl a t eb o r ns t r i a t a l
neurons,” Neuron, vol. 19, no. 1, pp. 27–37, 1997.
[24] O. Mar´ ın, S. A. Anderson, and J. L. R. Rubenstein, “Origin
and molecular speciﬁcation of striatal interneurons,” The
Journal of Neuroscience, vol. 20, no. 16, pp. 6063–6076, 2000.
[25] Q. Xu, I. Cobos, E. D. de La Cruz, J. L. Rubenstein, and S.
A. Anderson, “Origins of cortical interneuron subtypes,” The
Journal of Neuroscience, vol. 24, no. 11, pp. 2612–2622, 2004.
[26] T. Du, Q. Xu, P. J. Ocbina, and S. A. Anderson, “NKX2.1
speciﬁes cortical interneuron fate by activating Lhx6,” Devel-
opment, vol. 135, no. 8, pp. 1559–1567, 2008.
[27] Q. Xu, M. Tam, and S. A. Anderson, “Fate mapping
Nkx2.1-lineage cells in the mouse telencephalon,” Journal of
Comparative Neurology, vol. 506, no. 1, pp. 16–29, 2008.
[28] R. Batista-Brito, E. Rossignol, J. Hjerling-Leﬄer et al., “The
cell-intrinsic requirement of Sox6 for cortical interneuron
development,” Neuron, vol. 63, no. 4, pp. 466–481, 2009.
[29] J. Welagen and S. Anderson, “Origins of neocortical
interneurons in mice,” Developmental Neurobiology, vol. 71,
no. 1, pp. 10–17, 2011.
[30] J. L. Plotkin, N. Wu, M. F. Chesselet, and M. S. Levine,
“Functional and molecular development of striatal fast-
spiking GABAergic interneurons and their cortical inputs,”
European Journal of Neuroscience, vol. 22, no. 5, pp. 1097–
1108, 2005.
[31] M. F. Chesselet, J. L. Plotkin, N. Wu, and M. S. Levine,
“Development of striatal fast-spiking GABAergic interneu-
rons,” Progress in Brain Research, vol. 160, pp. 261–272, 2007.
[32] A. R. Woodruﬀ a n dP .S a h ,“ N e t w o r k so fp a r v a l b u m i n -
positive interneurons in the basolateral amygdala,” The
Journal of Neuroscience, vol. 27, no. 3, pp. 553–563, 2007.
[33] R. Batista-Brito, J. Close, R. Machold, and G. Fishell, “The
distinct temporal origins of olfactory bulb interneuron
subtypes,” The Journal of Neuroscience, vol. 28, no. 15, pp.
3966–3975, 2008.
[34] E. Likhtik, D. Popa, J. Apergis-Schoute, G. A. Fidacaro, and
D. Par´ e, “Amygdala intercalated neurons are required for
expression of fear extinction,” Nature, vol. 454, no. 7204, pp.
642–645, 2008.
[35] W. A. Truitt, P. L. Johnson, A. D. Dietrich, S. D. Fitz, and
A. Shekhar, “Anxiety-like behavior is modulated by a discrete
subpopulation of interneurons in the basolateral amygdala,”
Neuroscience, vol. 160, no. 2, pp. 284–294, 2009.
[36] S. Ciocchi, C. Herry, F. Grenier et al., “Encoding of condi-
tioned fear in central amygdala inhibitory circuits,” Nature,
vol. 468, no. 7321, pp. 277–282, 2010.
[37] L. Tricoire, K. A. Pelkey, M. I. Daw et al., “Common origins
of hippocampal ivy and nitric oxide synthase expressing
neurogliaform cells,” The Journal of Neuroscience, vol. 30, no.
6, pp. 2165–2176, 2010.
[38] R. R. Waclaw, L. A. Ehrman, A. Pierani, and K. Campbell,
“Developmental origin of the neuronal subtypes that com-
prise the amygdalar fear circuit in the mouse,” The Journal of
Neuroscience, vol. 30, no. 20, pp. 6944–6953, 2010.
[39] V. Ghiglieri, C. Sgobio, C. Costa, B. Picconi, and P. Calabresi,
“Striatum-hippocampus balance: from physiological behav-
ior to interneuronal pathology,” Progress in Neurobiology, vol.
94, no. 2, pp. 102–114, 2011.
[40] J. Spampanato, J. Polepalli, and P. Sah, “Interneurons in the
basolateral amygdala,” Neuropharmacology, vol. 60, pp. 765–
773, 2010.16 Neural Plasticity
[41] H. Wichterle, D. H. Turnbull, S. Nery, G. Fishell, and A.
Alvarez-Buylla, “In utero fate mapping reveals distinct
migratory pathways and fates of neurons born in the mam-
malian basal forebrain,” Development, vol. 128, no. 19, pp.
3759–3771, 2001.
[42] S.A.Anderson,C.E.Kaznowski,C.Horn,J.L.R.Rubenstein,
and S. K. McConnell, “Distinct origins of neocortical projec-
tion neurons and interneurons in vivo,” Cerebral Cortex, vol.
12, no. 7, pp. 702–709, 2002.
[43] S. Nery, G. Fishell, and J. G. Corbin, “The caudal ganglionic
eminence is a source of distinct cortical and subcortical cell
populations,” Nature Neuroscience, vol. 5, no. 12, pp. 1279–
1287, 2002.
[44] S. J. B. Butt, M. Fuccillo, S. Nery et al., “The temporal
and spatial origins of cortical interneurons predict their
physiological subtype,” Neuron, vol. 48, no. 4, pp. 591–604,
2005.
[45] G. Miyoshi, S. J. B. Butt, H. Takebayashi, and G.
Fishell, “Physiologically distinct temporal cohorts of corti-
cal interneurons arise from telencephalic Olig2-expressing
precursors,” The Journal of Neuroscience, vol. 27, no. 29, pp.
7786–7798, 2007.
[46] G. Miyoshi, J. Hjerling-Leﬄer, T. Karayannis et al., “Genetic
fate mapping reveals that the caudal ganglionic eminence
producesalargeanddiversepopulationofsuperﬁcialcortical
interneurons,” The Journal of Neuroscience, vol. 30, no. 5, pp.
1582–1594, 2010.
[47] D. M. Gelman, F. J. Martini, S. Nobrega-Pereira et al.,
“The embryonic preoptic area is a novel source of cortical
GABAergic interneurons,” The Journal of Neuroscience, vol.
29, no. 29, pp. 9380–9389, 2009.
[48] S. Lee, J. Hjerling-Leﬄe r ,E .Z a g h a ,G .F i s h e l l ,a n dB .R u d y ,
“The largest group of superﬁcial neocortical GABAergic
interneurons expresses ionotropic serotonin receptors,” The
Journal of Neuroscience, vol. 30, no. 50, pp. 16796–16808,
2010.
[49] I. F´ er´ e z o u ,B .C a u l i ,E .L .H i l l ,J .R o s s i e r ,E .H a m e l ,a n d
B. Lambolez, “5-HT3 receptors mediate serotonergic fast
synaptic excitation of neocortical vasoactive intestinal pep-
tide/cholecystokinin interneurons,” The Journal of Neuro-
science, vol. 22, no. 17, pp. 7389–7397, 2002.
[ 5 0 ]K .C a m p b e l l ,M .O l s s o n ,a n dA .B j ¨ orklund, “Regional
incorporation and site-speciﬁc diﬀerentiation of striatal pre-
cursors transplanted to the embryonic forebrain ventricle,”
Neuron, vol. 15, no. 6, pp. 1259–1273, 1995.
[51] C. P. Wonders and S. A. Anderson, “The origin and speciﬁca-
tion of cortical interneurons,” Nature Reviews Neuroscience,
vol. 7, no. 9, pp. 687–696, 2006.
[ 5 2 ]E .M .G o l d b e r g ,B .D .C l a r k ,E .Z a g h a ,M .N a h m a n i ,
A. Erisir, and B. Rudy, “K+ channels at the axon initial
segment dampen near-threshold excitability of neocortical
fast-spiking GABAergic interneurons,” Neuron, vol. 58, no.
3, pp. 387–400, 2008.
[53] M. Helmstaedter, B. Sakmann, and D. Feldmeyer, “Neuronal
correlates of local, lateral, and translaminar inhibition with
reference to cortical columns,” Cerebral Cortex, vol. 19, no. 4,
pp. 926–937, 2009.
[54] J .R.Gibson,M.Belerlein,andB.W .Connors,“T wonetworks
of electrically coupled inhibitory neurons in neocortex,”
Nature, vol. 402, no. 6757, pp. 75–79, 1999.
[55] A. Erisir, D. Lau, B. Rudy, and C. S. Leonard, “Function of
speciﬁc K+ channels in sustained high-frequency ﬁring of
fast-spiking neocortical interneurons,” Journal of Neurophys-
iology, vol. 82, no. 5, pp. 2476–2489, 1999.
[56] B. Rudy, A. Chow, D. Lau et al., “Contributions of Kv3
channels to neuronal excitability,” Annals of the New York
Academy of Sciences, vol. 868, pp. 304–343, 1999.
[57] D. Lau, E. C. Vega-Saenz de Miera, D. Contreras et al.,
“Impaired fast-spiking, suppressed cortical inhibition, and
increased susceptibility to seizures in mice lacking Kv3.2 K+
channelproteins,”TheJournalofNeuroscience,vol.20,no.24,
pp. 9071–9085, 2000.
[58] B. Rudy and C. J. McBain, “Kv3 channels: voltage-gated
K+ channels designed for high-frequency repetitive ﬁring,”
Trends in Neurosciences, vol. 24, no. 9, pp. 517–526, 2001.
[59] S.Y.Chang,E.Zagha,E.S.Kwonetal.,“DistributionofKv3.3
potassium channel subunits in distinct neuronal populations
of mouse brain,” Journal of Comparative Neurology, vol. 502,
no. 6, pp. 953–972, 2007.
[60] A. V. Zaitsev, N. V. Povysheva, D. A. Lewis, and L. S. Krimer,
“P/Q-type, but not N-type, calcium channels mediate GABA
release from fast-spiking interneurons to pyramidal cells in
rat prefrontal cortex,” J o u r n a lo fN e u r o p h y s i o l o gy , vol. 97, no.
5, pp. 3567–3573, 2007.
[61] I. Bucurenciu, A. Kulik, B. Schwaller, M. Frotscher, and P.
Jonas, “Nanodomain coupling between Ca2+ channels and
Ca2+ sensors promotes fast and eﬃcient transmitter release
at a cortical GABAergic synapse,” Neuron,v o l .5 7 ,n o .4 ,p p .
536–545, 2008.
[62] I. Kruglikov and B. Rudy, “Perisomatic GABA release and
thalamocortical integration onto neocortical excitatory cells
areregulatedbyneuromodulators,”Neuron,v ol.58,no .6,pp .
911–924, 2008.
[63] E. Rossignol, I. Kruglikov, A. M. J. M. van den Maagdenberg,
G. Fishell, and B. Rudy, “Defective cortical signaling results
in generalised seizures,” in Proceedings of the 40th Annual
MeetingofNeuroscience,SocietyforNeuroscience,SanDiego,
Calif, USA, 2010.
[64] D. J. Pinto, J. C. Brumberg, and D. J. Simons, “Circuit
dynamics and coding strategies in rodent somatosensory
cortex,” J o u r n a lo fN e u r o p h y s i o l o g y , vol. 83, no. 3, pp. 1158–
1166, 2000.
[65] D. J. Pinto, J. A. Hartings, J. C. Brumberg, and D. J. Simons,
“Cortical damping: analysis of thalamocortical response
transformationsinrodentbarrelcortex,”CerebralCortex,vol.
13, no. 1, pp. 33–44, 2003.
[66] L. Gabernet, S. P. Jadhav, D. E. Feldman, M. Carandini,
and M. Scanziani, “Somatosensory integration controlled by
dynamic thalamocortical feed-forward inhibition,” Neuron,
vol. 48, no. 2, pp. 315–327, 2005.
[67] S. J. Cruikshank, T. J. Lewis, and B. W. Connors, “Synaptic
basis for intense thalamocortical activation of feedforward
inhibitory cells in neocortex,” Nature Neuroscience, vol. 10,
no. 4, pp. 462–468, 2007.
[68] F.Pouille,A.Marin-Burgin,H.Adesnik,B.V.Atallah,andM.
Scanziani, “Input normalization by global feedforward inhi-
bition expands cortical dynamic range,” Nature Neuroscience,
vol. 12, no. 12, pp. 1577–1585, 2009.
[69] G. Tamas, E. H. Buhl, A. Lorincz, and P. Somogyi, “Prox-
imally targeted G.ABAergic synapses and gap junctions
synchronize cortical interneurons,” Nature Neuroscience, vol.
3, no. 4, pp. 366–371, 2000.
[70] J. Szabadics, A. Lorincz, and G. Tamas, “Beta and gamma
frequency synchronization by dendritic gabaergic synapses
and gap junctions in a network of cortical interneurons,” The
Journal of Neuroscience, vol. 21, no. 15, pp. 5824–5831, 2001.Neural Plasticity 17
[71] M. R. Deans, J. R. Gibson, C. Sellitto, B. W. Connors, and D.
L. Paul, “Synchronous activity of inhibitory networks in neo-
cortex requires electrical synapses containing connexin36,”
Neuron, vol. 31, no. 3, pp. 477–485, 2001.
[72] M. Bartos, I. Vida, M. Frotscher et al., “Fast synaptic inhi-
bition promotes synchronized gamma oscillations in hip-
pocampal interneuron networks,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 99,
no. 20, pp. 13222–13227, 2002.
[73] R. D. Traub, M. O. Cunningham, T. Gloveli et al., “GABA-
enhanced collective behavior in neuronal axons underlies
persistent gamma-frequency oscillations,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 100, no. 19, pp. 11047–11052, 2003.
[ 7 4 ] R .D .T r a u b ,A .B i b b i g ,F .E .N .L e B e a u ,E .H .B u h l ,a n dM .A .
Whittington, “Cellular mechanisms of neuronal population
oscillations in the hippocampus in vitro,” Annual Review of
Neuroscience, vol. 27, pp. 247–278, 2004.
[75] R. D. Traub, H. Michelson-Law, A. E. J. Bibbig, E. H. Buhl,
and M. A. Whittington, “Gap junctions, fast oscillations and
the initiation of seizures,” Advances in Experimental Medicine
and Biology, vol. 548, pp. 110–122, 2004.
[76] M. Bartos, I. Vida, and P. Jonas, “Synaptic mechanisms of
synchronized gamma oscillations in inhibitory interneuron
networks,” Nature Reviews Neuroscience, vol. 8, no. 1, pp. 45–
56, 2007.
[77] J. A. Cardin, M. Carl´ en, K. Meletis et al., “Driving fast-
spiking cells induces gamma rhythm and controls sensory
responses,” Nature, vol. 459, no. 7247, pp. 663–667, 2009.
[78] D. L. Buhl, K. D. Harris, S. G. Hormuzdi, H. Monyer, and
G. Buzs´ aki, “Selective impairment of hippocampal gamma
oscillations in connexin-36 knock-out mouse in vivo,” The
Journal of Neuroscience, vol. 23, no. 3, pp. 1013–1018, 2003.
[79] C. Tallon-Baudry, O. Bertrand, F. Peronnet, and J. Pernier,
“Induced γ-band activity during the delay of a visual short-
term memory task in humans,” The Journal of Neuroscience,
vol. 18, no. 11, pp. 4244–4254, 1998.
[80] P. Fries, J. H. Reynolds, A. E. Rorie, and R. Desimone,
“Modulation of oscillatory neuronal synchronization by
selective visual attention,” Science, vol. 291, no. 5508, pp.
1560–1563, 2001.
[ 8 1 ]M .W .H o w a r d ,D .S .R i z z u t o ,J .B .C a p l a ne ta l . ,“ G a m m a
oscillationscorrelatewithworkingmemoryloadinhumans,”
Cerebral Cortex, vol. 13, no. 12, pp. 1369–1374, 2003.
[82] K. M. Spencer, P. G. Nestor, M. A. Niznikiewicz, D. F. Salis-
bury, M. E. Shenton, and R. W. McCarley, “Abnormal neural
synchronyinschizophrenia,”TheJournalofNeuroscience,vol.
23, no. 19, pp. 7407–7411, 2003.
[83] V. S. Sohal, F. Zhang, O. Yizhar, and K. Deisseroth, “Parval-
bumin neurons and gamma rhythms enhance cortical circuit
performance,” Nature, vol. 459, no. 7247, pp. 698–702, 2009.
[84] K. M. Spencer, P. G. Nestor, R. Perlmutter et al., “Neural
synchrony indexes disordered perception and cognition
in schizophrenia,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 101, no. 49, pp.
17288–17293, 2004.
[85] R. Y. Cho, R. O. Konecky, and C. S. Carter, “Impairments
in frontal cortical γ synchrony and cognitive control in
schizophrenia,” Proceedings of the National Academy of Sci-
ences of the United States of America, vol. 103, no. 52, pp.
19878–19883, 2006.
[86] Y. Kawaguchi, “Physiological subgroups of nonpyramidal
cells with speciﬁc morphological characteristics in layer II/III
of rat frontal cortex,” The Journal of Neuroscience, vol. 15, no.
4, pp. 2638–2655, 1995.
[87] G. Gonzalez-Burgos, L. S. Krimer, N. V. Povysheva, G.
Barrionuevo, and D. A. Lewis, “Functional properties of fast
spiking interneurons and their synaptic connections with
pyramidal cells in primate dorsolateral prefrontal cortex,”
Journal of Neurophysiology, vol. 93, no. 2, pp. 942–953, 2005.
[88] E.G.Jones,“Varietiesanddistributionofnonpyramidalcells
inthesomaticsensorycortexofthesquirrelmonkey,”Journal
of Comparative Neurology, vol. 160, no. 2, pp. 205–267, 1975.
[89] A. Fairen and F. Valverde, “A specialized type of neuron in
the visual cortex of cat: golgi golgi and electron microscope
study of chandelier cells,” Journal of Comparative Neurology,
vol. 194, no. 4, pp. 761–779, 1980.
[90] J. DeFelipe, S. H. C. Hendry, and E. G. Jones, “Visualization
ofchandelier cellaxonsbyparvalbuminimmunoreactivityin
monkeycerebralcortex,”ProceedingsoftheNationalAcademy
of Sciences of the United States of America,v o l .8 6 ,n o .6 ,p p .
2093–2097, 1989.
[91] P. Somogyi, “A speciﬁc “axo-axonal” interneuron in the
visual cortex of the rat,” Brain Research, vol. 136, no. 2, pp.
345–350, 1977.
[92] J. Szabadics, C. Varga, G. Molnar, S. Olah, P. Barzo, and G.
Tamas, “Excitatory eﬀect of GABAergic axo-axonic cells in
cortical microcircuits,” Science, vol. 311, no. 5758, pp. 233–
235, 2006.
[93] S. Khirug, J. Yamada, R. Afzalov, J. Voipio, L. Khiroug, and K.
Kaila, “GABAergic depolarization of the axon initial segment
in cortical principal neurons is caused by the Na-K-2Cl
cotransporter NKCC1,” The Journal of Neuroscience, vol. 28,
no. 18, pp. 4635–4639, 2008.
[94] A. R. Woodruﬀ, Q. Xu, S. A. Anderson, and R. Yuste,
“Depolarizing eﬀect of neocortical chandelier neurons,”
Frontiers in Neural Circuits, vol. 3, no. 15, 10 pages, 2009.
[95] A. R. Woodruﬀ, S. A. Anderson, R. Yuste et al., “The enig-
matic function of chandelier cells,” Frontiers in Neuroscience,
vol. 4, article 201, 2010.
[96] L. L. Glickfeld, J. D. Roberts, P. Somogyi, and M. Scanziani,
“Interneurons hyperpolarize pyramidal cells along their
entiresomatodendriticaxis,”Nature Neuroscience,vol.12,no.
1, pp. 21–23, 2009.
[97] T. Klausberger, P. J. Magill, L. F. Marton et al., “Brain-state
and cell-type-speciﬁc ﬁring of hippocampal interneurons in
vivo,” Nature, vol. 421, no. 6925, pp. 844–848, 2003.
[98] B. Halabisky, F. Shen, J. R. Huguenard, and D. A. Prince,
“Electrophysiological classiﬁcation of somatostatin-positive
interneurons in mouse sensorimotor cortex,” Journal of
Neurophysiology, vol. 96, no. 2, pp. 834–845, 2006.
[ 9 9 ]Y .M a ,H .H u ,A .S .B e r r e b i ,P .H .M a t h e r s ,a n dA .A g m o n ,
“Distinct subtypes of somatostatin-containing neocortical
interneurons revealed in transgenic mice,” The Journal of
Neuroscience, vol. 26, no. 19, pp. 5069–5082, 2006.
[100] L. M. McGarry, A. M. Packer, E. Fino, V. Nikolenko, T. Sippy,
and R. Yuste, “Quantitative classiﬁcation of somatostatin-
positiveneocorticalinterneuronsidentiﬁesthreeinterneuron
subtypes,”FrontiersinNeuralCircuits,vol.4,no.12,19pages,
2010.
[101] E. E. Fanselow, K. A. Richardson, and B. W. Connors, “Selec-
tive, state-dependent activation of somatostatin-expressing
inhibitory interneurons in mouse neocortex,” Journal of
Neurophysiology, vol. 100, no. 5, pp. 2640–2652, 2008.
[102] Y. Wang, M. Toledo-Rodriguez, A. Gupta et al., “Anatomical,
physiological and molecular properties of Martinotti cells18 Neural Plasticity
in the somatosensory cortex of the juvenile rat,” Journal of
Physiology, vol. 561, no. 1, pp. 65–90, 2004.
[103] M.Uematsu,Y.Hirai,F.Karubeetal.,“Quantitativechemical
composition of cortical GABAergic neurons revealed in
transgenic venus-expressing rats,” Cerebral Cortex, vol. 18,
no. 2, pp. 315–330, 2008.
[104] M. Murayama, E. P´ erez-Garci, T. Nevian, T. Bock, W. Senn,
and M. E. Larkum, “Dendritic encoding of sensory stimuli
controlled by deep cortical interneurons,” Nature, vol. 457,
no. 7233, pp. 1137–1141, 2009.
[105] G. Silberberg and H. Markram, “Disynaptic inhibition
between neocortical pyramidal cells mediated by martinotti
cells,” Neuron, vol. 53, no. 5, pp. 735–746, 2007.
[106] T. K. Berger, R. Perin, G. Silberberg, and H. Markram,
“Frequency-dependent disynaptic inhibition in the pyrami-
dal network: a ubiquitous pathway in the developing rat
neocortex,” Journal of Physiology, vol. 587, no. 22, pp. 5411–
5425, 2009.
[107] E. E. Fanselow and B. W. Connors, “The roles of
somatostatin-expressing (GIN) and fast-spiking inhibitory
interneurons in UP-DOWN states of mouse neocortex,”
JournalofNeurophysiology,vol.104,no.2,pp.596–606,2010.
[108] R. Cossart, C. Dinocourt, J. C. Hirsch et al., “Dendritic
but not somatic GABAergic inhibition is decreased in
experimental epilepsy,” Nature Neuroscience,v o l .4 ,n o .1 ,p p .
52–62, 2001.
[109] D. W. Volk, M. C. Austin, J. N. Pierri, A. R. Sampson, and
D. A. Lewis, “Decreased glutamic acid decarboxylase67 mes-
senger RNA expression in a subset of prefrontal cortical γ-
aminobutyric acid neurons in subjects with schizophrenia,”
Archives of General Psychiatry, vol. 57, no. 3, pp. 237–245,
2000.
[110] S. Akbarian, J. J. Kim, S. G. Potkin et al., “Gene expression
for glutamic acid decarboxylase is reduced without loss of
neurons in prefrontal cortex of schizophrenics,” Archives of
General Psychiatry, vol. 52, no. 4, pp. 258–278, 1995.
[111] T. U. Woo, J. L. Miller, and D. A. Lewis, “Schizophrenia
and the parvalbumin-containing class of cortical local circuit
neurons,” American Journal of Psychiatry, vol. 154, no. 7, pp.
1013–1015, 1997.
[112] T. Hashimoto, D. W. Volk, S. M. Eggan et al., “Gene expres-
sion deﬁcits in a subclass of GABA neurons in the prefrontal
cortex of subjects with schizophrenia,” The Journal of Neuro-
science, vol. 23, no. 15, pp. 6315–6326, 2003.
[113] A. M. Addington, M. Gornick, J. Duckworth et al., “GAD1
(2q31.1), which encodes glutamic acid decarboxylase
(GAD67), is associated with childhood-onset schizophrenia
a n dc o r t i c a lg r a ym a t t e rv o l u m el o s s , ”Molecular Psychiatry,
vol. 10, no. 6, pp. 581–588, 2005.
[114] T.U.Woo,R.E.Whitehead,D.S.Melchitzky,andD.A.Lewis,
“A subclass of prefrontal γ-aminobutyric acid axon terminals
are selectively altered in schizophrenia,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 95, no. 9, pp. 5341–5346, 1998.
[115] D. W. Volk, M. C. Austin, J. N. Pierri, A. R. Sampson, and
D. A. Lewis, “GABA transporter-1 mRNA in the prefrontal
cortex in schizophrenia: decreased expression in a subset of
neurons,” American Journal of Psychiatry, vol. 158, no. 2, pp.
256–265, 2001.
[116] T. Hashimoto, D. Arion, T. Unger et al., “Alterations in
GABA-related transcriptome in the dorsolateral prefrontal
cortex of subjects with schizophrenia,” Molecular Psychiatry,
vol. 13, no. 2, pp. 147–161, 2008.
[117] H. Stefansson, E. Sigurdsson, V. Steinthorsdottir et al.,
“Neuregulin 1 and susceptibility to schizophrenia,” American
Journal of Human Genetics, vol. 71, no. 4, pp. 877–892, 2002.
[118] H. Stefansson, J. Sarginson, A. Kong et al., “Association of
neuregulin 1 with schizophrenia conﬁrmed in a Scottish
population,” American Journal of Human Genetics, vol. 72,
no. 1, pp. 83–87, 2003.
[119] H. X. Zhang, W. Q. Li, Y. Zhang, J. P. Zhao, L. X. Lv, and
G. Yang, “Association analysis of neuregulin 1 gene poly-
morphism with schizophrenia in Chinese Han population,”
Zhonghua Yi Xue Yi Chuan Xue Za Zhi,v o l .2 6 ,n o .1 ,p p .
16–20, 2009.
[120] J. Z. Yang, T. M. Si, Y. Ruan et al., “Association study of
neuregulin 1 gene with schizophrenia,” Molecular Psychiatry,
vol. 8, no. 7, pp. 706–709, 2003.
[121] G. Silberberg, A. Darvasi, R. Pinkas-Kramarski, and R.
Navon, “The involvement of ErbB4 with schizophrenia:
association and expression studies,” American Journal of
Medical Genetics Part B, vol. 141, no. 2, pp. 142–148, 2006.
[122] C. S. Weickert, T. M. Hyde, B. K. Lipska, M. M. Herman, D.
R. Weinberger, and J. E. Kleinman, “Reduced brain-derived
neurotrophic factor in prefrontal cortex of patients with
schizophrenia,” Molecular Psychiatry, vol. 8, no. 6, pp. 592–
610, 2003.
[123] J. Wong, T. M. Hyde, H. L. Cassano, A. Deep-Soboslay,
J. E. Kleinman, and C. S. Weickert, “Promoter speciﬁc
alterations of brain-derived neurotrophic factor mRNA in
schizophrenia,” Neuroscience, vol. 169, no. 3, pp. 1071–1084,
2010.
[124] M. Takahashi, O. Shirakawa, K. Toyooka et al., “Abnor-
mal expression of brain-derived neurotrophic factor and
its receptor in the corticolimbic system of schizophrenic
patients,” Molecular Psychiatry, vol. 5, no. 3, pp. 293–300,
2000.
[125] D. Barbeau, J. J. Liang, Y. Robitaille, R. Quirion, and L. K.
Srivastava, “Decreased expression of the embryonic form of
the neural cell adhesion molecule in schizophrenic brains,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 92, no. 7, pp. 2785–2789, 1995.
[126] L. Wen, Y. S. Lu, X. H. Zhu et al., “Neuregulin 1 regulates
pyramidalneuronactivityviaErbB4inparvalbumin-positive
interneurons,”ProceedingsoftheNationalAcademyofSciences
oftheUnitedStatesofAmerica,vol.107,no.3,pp.1211–1216,
2010.
[127] Y. J. Chen, M. Zhang, D. M. Yin et al., “ErbB4 in par-
valbumin-positive interneurons is critical for neuregulin 1
regulation of long-term potentiation,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 107, no. 50, pp. 21818–21823, 2010.
[128] J. E. Belforte, V. Zsiros, E. R. Sklar et al., “Postnatal NMDA
receptor ablation in corticolimbic interneurons confers
schizophrenia-likephenotypes,”Nature Neuroscience,vol.13,
no. 1, pp. 76–83, 2010.
[129] Z. J. Huang, A. Kirkwood, T. Pizzorusso et al., “BDNF
regulates the maturation of inhibition and the critical period
of plasticity in mouse visual cortex,” Cell,v o l .9 8 ,n o .6 ,p p .
739–755, 1999.
[130] T. Cotrufo, A. Viegi, N. Berardi, Y. Bozzi, L. Mascia, and
L. Maﬀei, “Eﬀects of neurotrophins on synaptic protein
expression in the visual cortex of dark-reared rats,” The
Journal of Neuroscience, vol. 23, no. 9, pp. 3566–3571, 2003.
[131] T.Hashimoto,S.E.Bergen,Q.L.Nguyenetal.,“Relationship
of brain-derived neurotrophic factor and its receptor TrkB toNeural Plasticity 19
altered inhibitory prefrontal circuitry in schizophrenia,” The
Journal of Neuroscience, vol. 25, no. 2, pp. 372–383, 2005.
[132] G. Di Cristo, B. Chattopadhyaya, S. J. Kuhlman et al.,
“Activity-dependent PSA expression regulates inhibitory
maturation and onset of critical period plasticity,” Nature
Neuroscience, vol. 10, no. 12, pp. 1569–1577, 2007.
[133] A. Levitas, R. J. Hagerman, M. Braden, B. Rimland, P.
McBogg, and I. Matus, “Autism and the fragile X syndrome,”
Journal of Developmental & Behavioral Pediatrics, vol. 4, no.
3, pp. 151–158, 1983.
[134] W. T. Brown, E. C. Jenkins, I. L. Cohen et al., “Fragile X and
autism: a multicenter survey,” American Journal of Medical
Genetics, vol. 23, no. 1-2, pp. 341–352, 1986.
[135] S. Jamain, H. Quach, C. Betancur et al., “Mutations of the X-
linked genes encoding neuroligins NLGN3 and NLGN4 are
associated with autism,” Nature Genetics,v o l .3 4 ,n o .1 ,p p .
27–29, 2003.
[136] F. Laumonnier, F. Bonnet-Brilhault, M. Gomot et al., “X-
linked mental retardation and autism are associated with a
mutation in the NLGN4 gene, a member of the neuroligin
family,” American Journal of Human Genetics, vol. 74, no. 3,
pp. 552–557, 2004.
[137] C. M. Durand, C. Betancur, T. M. Boeckers et al., “Muta-
tions in the gene encoding the synaptic scaﬀolding protein
SHANK3 are associated with autism spectrum disorders,”
Nature Genetics, vol. 39, no. 1, pp. 25–27, 2007.
[138] J. Gauthier, D. Spiegelman, A. Piton et al., “Novel de novo
SHANK3 mutation in autistic patients,” American Journal of
Medical Genetics Part B, vol. 150, no. 3, pp. 421–424, 2009.
[139] R. Moessner, C. R. Marshall, J. S. Sutcliﬀe et al., “Contri-
bution of SHANK3 mutations to autism spectrum disorder,”
AmericanJournalofHumanGenetics,vol.81,no.6,pp.1289–
1297, 2007.
[140] S. Berkel, C. R. Marshall, B. Weiss et al., “Mutations in
t h eS H A N K 2s y n a p t i cs c a ﬀolding gene in autism spectrum
disorder and mental retardation,” Nature Genetics, vol. 42,
no. 6, pp. 489–491, 2010.
[141] P. Szatmari, A. D. Paterson, L. Zwaigenbaum et al., “Mapping
autism risk loci using genetic linkage and chromosomal
rearrangements,”Nature Genetics,vol.39,no.3,pp.319–328,
2007.
[142] H. G. Kim, S. Kishikawa, A. W. Higgins et al., “Disruption
of neurexin 1 associated with autism spectrum disorder,”
American Journal of Human Genetics, vol. 82, no. 1, pp. 199–
207, 2008.
[143] S. H. Fatemi, A. R. Halt, J. M. Stary, R. Kanodia, S. C. Schulz,
and G. R. Realmuto, “Glutamic acid decarboxylase 65 and 67
kDa proteins are reduced in autistic parietal and cerebellar
cortices,” Biological Psychiatry, vol. 52, no. 8, pp. 805–810,
2002.
[144] X. Liu, N. Novosedlik, A. Wang et al., “The DLX1and
DLX2genesandsusceptibilitytoautismspectrumdisorders,”
European Journal of Human Genetics, vol. 17, no. 2, pp. 228–
235, 2009.
[145] P. Baker, J. Piven, S. Schwartz, and S. Patil, “Brief report:
duplication of chromosome 15q11-13 in two individuals
with autistic disorder,” Journal of Autism and Developmental
Disorders, vol. 24, no. 4, pp. 529–535, 1994.
[146] A. Hogart, D. Wu, J. M. LaSalle, and N. C. Schanen,
“The comorbidity of autism with the genomic disorders of
chromosome 15q11.2-q13,” Neurobiology of Disease, vol. 38,
no. 2, pp. 181–191, 2010.
[147] R. E. Amir, I. B. van den Veyver, M. Wan, C. Q. Tran,
U. Francke, and H. Y. Zoghbi, “Rett syndrome is caused
by mutations in X-linked MECP2, encoding methyl-CpG-
binding protein 2,” Nature Genetics, vol. 23, no. 2, pp. 185–
188, 1999.
[148] I.M.Buyse,P.Fang,K.T.Hoon,R.E.Amir,H.Y.Zoghbi,and
B. B. Roa, “Diagnostic testing for Rett syndrome by DHPLC
and direct sequencing analysis of the MECP2 gene: iden-
tiﬁcation of several novel mutations and polymorphisms,”
AmericanJournalofHumanGenetics,vol.67,no.6,pp.1428–
1436, 2000.
[149] P. B. Jackson, L. Boccuto, C. Skinner et al., “Further evidence
that the rs1858830 C variant in the promoter region of
the MET gene is associated with autistic disorder,” Autism
Research, vol. 2, no. 4, pp. 232–236, 2009.
[150] D. B. Campbell, J. S. Sutcliﬀe, P. J. Ebert et al., “A genetic
variant that disrupts MET transcription is associated with
autism,”ProceedingsoftheNationalAcademyofSciencesofthe
United States of America, vol. 103, no. 45, pp. 16834–16839,
2006.
[151] G. D¨ olen, E. Osterweil, B. S. S. Rao et al., “Correction of
fragile X syndrome in mice,” Neuron, vol. 56, no. 6, pp. 955–
962, 2007.
[152] M. F. Bear, K. M. Huber, and S. T. Warren, “The mGluR the-
ory of fragile X mental retardation,” Trends in Neurosciences,
vol. 27, no. 7, pp. 370–377, 2004.
[153] M.F.Bear,G.D¨ olen,E.Osterweil,andN.Nagarajan,“Fragile
X: translation in action,” Neuropsychopharmacology, vol. 33,
no. 1, pp. 84–87, 2008.
[154] P. Scheiﬀele, J. Fan, J. Choih, R. Fetter, and T. Seraﬁni, “Neu-
roligin expressed in nonneuronal cells triggers presynaptic
development in contacting axons,” Cell, vol. 101, no. 6, pp.
657–669, 2000.
[155] B. Chih, H. Engelman, P. Scheiﬀele et al., “Control of
excitatory and inhibitory synapse formation by neuroligins,”
Science, vol. 307, no. 5713, pp. 1324–1328, 2005.
[156] E. R. Graf, X. Zhang, S. X. Jin, M. W. Linhoﬀ,a n dA .
M. Craig, “Neurexins induce diﬀerentiation of GABA and
glutamate postsynaptic specializations via neuroligins,” Cell,
vol. 119, no. 7, pp. 1013–1026, 2004.
[157] R. C. Samaco, A. Hogart, and J. M. LaSalle, “Epigenetic
overlap in autism-spectrum neurodevelopmental disorders:
MECP2 deﬁciency causes reduced expression of UBE3A and
GABRB3,” HumanMolecularGenetics,vol.14,no.4,pp.483–
492, 2005.
[158] H. T. Chao, H. Chen, R. C. Samaco et al., “Dysfunction in
GABA signalling mediates autism-like stereotypies and Rett
syndrome phenotypes,” Nature, vol. 468, no. 7321, pp. 263–
269, 2010.
[159] E. M. Powell, W. M. Mars, and P. Levitt, “Hepatocyte growth
factor/scatter factor is a motogen for interneurons migrating
fromtheventraltodorsaltelencephalon,”Neuron,vol.30,no.
1, pp. 79–89, 2001.
[160] M. H. Bae, G. B. Bissonette, W. M. Mars et al., “Hepatocyte
growth factor (HGF) modulates GABAergic inhibition and
seizure susceptibility,” Experimental Neurology, vol. 221, no.
1, pp. 129–135, 2010.
[161] G. J. Martins, M. Shahrokh, and E. M. Powell, “Genetic
disruption of Met signaling impairs GABAergic striatal
development and cognition,” Neuroscience, vol. 176, no. 10,
pp. 199–209, 2010.
[162] L. Claes, J. Del-Favero, B. Ceulemans, L. Lagae, C. van
Broeckhoven, and P. de Jonghe, “De novo mutations in
the sodium-channel gene SCN1A cause severe myoclonic
epilepsy of infancy,” American Journal of Human Genetics,
vol. 68, no. 6, pp. 1327–1332, 2001.20 Neural Plasticity
[163] I. Ohmori, M. Ouchida, Y. Ohtsuka, E. Oka, and K. Shimizu,
“Signiﬁcant correlation of the SCN1A mutations and severe
myoclonic epilepsy in infancy,” Biochemical and Biophysical
Research Communications, vol. 295, no. 1, pp. 17–23, 2002.
[164] T. Sugawara, E. Mazaki-Miyazaki, K. Fukushima et al.,
“Frequent mutations of SCN1A in severe myoclonic epilepsy
in infancy,” Neurology, vol. 58, no. 7, pp. 1122–1124, 2002.
[165] A.Orrico,L.Galli,S.Grossoetal.,“Mutationalanalysisofthe
SCN1A, SCN1B and GABRG2 genes in 150 Italian patients
with idiopathic childhood epilepsies,” Clinical Genetics, vol.
75, no. 6, pp. 579–581, 2009.
[166] A. Escayg and A. L. Goldin, “Sodium channel SCN1A and
epilepsy: mutations and mechanisms,” Epilepsia, vol. 51, no.
9, pp. 1650–1658, 2010.
[167] A. Escayg, B. T. MacDonald, M. H. Meisler et al., “Mutations
of SCN1A, encoding a neuronal sodium channel, in two
families with GEFS+2,” Nature Genetics,v o l .2 4 ,n o .4 ,p p .
343–345, 2000.
[168] A. Escayg, A. Heils, B. T. Macdonald, K. Haug, T. Sander,
a n dM .H .M e i s l e r ,“ An o v e lSCN1A mutation associated
with generalized epilepsy with febrile seizures plus—and
prevalence of variants in patients with epilepsy,” American
Journal of Human Genetics, vol. 68, no. 4, pp. 866–873, 2001.
[169] T. Fujiwara, T. Sugawara, E. Mazaki-Miyazaki et al., “Muta-
tions of sodium channel α subunit type 1 (SCN1A) in
intractable childhood epilepsies with frequent generalized
tonic-clonic seizures,” Brain, vol. 126, no. 3, pp. 531–546,
2003.
[170] H. Osaka, I. Ogiwara, E. Mazaki et al., “Patients with a
sodium channel alpha 1 gene mutation show wide pheno-
typic variation,” Epilepsy Research, vol. 75, no. 1, pp. 46–51,
2007.
[171] C.Zucca,F.Redaelli,R.Epifanioetal.,“Cryptogenicepileptic
syndromes related to SCN1A: twelve novel mutations identi-
ﬁed,” Archives of Neurology, vol. 65, no. 4, pp. 489–494, 2008.
[172] M. S. Martin, B. Tang, L. A. Papale, F. H. Yu, W. A. Catterall,
and A. Escayg, “The voltage-gated sodium channel Scn8a is
a genetic modiﬁer of severe myoclonic epilepsy of infancy,”
Human Molecular Genetics, vol. 16, no. 23, pp. 2892–2899,
2007.
[173] I. Ohmori, M. Ouchida, T. Miki et al., “A CACNB4 mutation
shows that altered Cav2.1 function may be a genetic modiﬁer
of severe myoclonic epilepsy in infancy,” Neurobiology of
Disease, vol. 32, no. 3, pp. 349–354, 2008.
[174] R. H. Wallace, C. Marini, S. Petrou et al., “Mutant GABAA
receptor γ2-subunit in childhood absence epilepsy and
febrile seizures,” Nature Genetics, vol. 28, no. 1, pp. 49–52,
2001.
[175] C. Shoubridge, T. Fullston, and J. G´ ecz, “ARX spectrum
disorders: making inroads into the molecular pathology,”
Human Mutation, vol. 31, no. 8, pp. 889–900, 2010.
[176] V. M. Kalscheuer, J. Tao, A. Donnelly et al., “Disruption of
the serine/threonine kinase 9 gene causes severe X-linked
infantile spasms and mental retardation,” American Journal
of Human Genetics, vol. 72, no. 6, pp. 1401–1411, 2003.
[177] L. S. Weaving, J. Christodoulou, S. L. Williamson et al.,
“Mutations of CDKL5 cause a severe neurodevelopmental
disorder with infantile spasms and mental retardation,”
AmericanJournalofHumanGenetics,vol.75,no.6,pp.1079–
1093, 2004.
[178] E. Scala, F. Ariani, F. Mari et al., “CDKL5/STK9 is mutated
in Rett syndrome variant with infantile spasms,” Journal of
Medical Genetics, vol. 42, no. 2, pp. 103–107, 2005.
[179] H. L. Archer, J. Evans, S. Edwards et al., “CDKL5 mutations
causeinfantilespasms,earlyonsetseizures,andseveremental
retardation in female patients,” Journal of Medical Genetics,
vol. 43, no. 9, pp. 729–734, 2006.
[180] C. Cordova-Fletes, N. Rademacher, I. Muller et al., “CDKL5
truncation due to a t(X;2)(p22.1;p25.3) in a girl with X-
linked infantile spasm syndrome,” Clinical Genetics, vol. 77,
no. 1, pp. 92–96, 2010.
[181] D. Mei, C. Marini, F. Novara et al., “Xp22.3 genomic
deletions involving the CDKL5 gene in girls with early onset
epileptic encephalopathy,” Epilepsia, vol. 51, no. 4, pp. 647–
654, 2010.
[182] F. Melani, D. Mei, T. Pisano et al., “CDKL5 gene-related
epileptic encephalopathy: electroclinical ﬁndings in the ﬁrst
year of life,” Developmental Medicine and Child Neurology,
vol. 53,, no. 4, pp. 354–360, 2010.
[183] C. Kananura, K. Haug, T. Sander et al., “A splice-site
mutation in GABRG2 associated with childhood absence
epilepsy and febrile convulsions,” Archives of Neurology, vol.
59, no. 7, pp. 1137–1141, 2002.
[184] L. A. Harkin, D. N. Bowser, L. M. Dibbens et al., “Truncation
of the GABAA-receptor γ2 subunit in a family with general-
ized epilepsy with febrile seizures plus,” American Journal of
Human Genetics, vol. 70, no. 2, pp. 530–536, 2002.
[185] P. Cossette, L. Liu, K. Brisebois et al., “Mutation of GABRA1
in an autosomal dominant form of juvenile myoclonic
epilepsy,” Nature Genetics, vol. 31, no. 2, pp. 184–189, 2002.
[186] S. Maljevic, K. Krampﬂ, J. Cobilanschi et al., “A mutation in
the GABAA receptor α1-subunit is associated with absence
epilepsy,” Annals of Neurology, vol. 59, pp. 983–987, 2006.
[187] B. Chioza, H. Wilkie, L. Nashef et al., “Association between
the α1a calcium channel gene CACNA1A and idiopathic
generalized epilepsy,” Neurology, vol. 56, no. 9, pp. 1245–
1246, 2001.
[188] A. Jouvenceau, L. H. Eunson, A. Spauschus et al., “Human
epilepsy associated with dysfunction of the brain P/Q-type
calcium channel,” The Lancet, vol. 358, no. 9284, pp. 801–
807, 2001.
[189] P. Imbrici, S. L. Jaﬀe, L. H. Eunson et al., “Dysfunction of
the brain calcium channel Cav2.1 in absence epilepsy and
episodic ataxia,” Brain, vol. 127, no. 12, pp. 2682–2692, 2004.
[190] A. Escayg, M. de Waard, D. D. Lee et al., “Coding and
noncoding variation of the human calcium-channel β4-
subunitgeneCACNB4inpatientswithidiopathicgeneralized
epilepsy and episodic ataxia,” American Journal of Human
Genetics, vol. 66, no. 5, pp. 1531–1539, 2000.
[191] H. Khosravani, C. Altier, B. Simms et al., “Gating eﬀects of
mutations in the Cav3.2 T-type calcium channel associated
with childhood absence epilepsy,” Journal of Biological Chem-
istry, vol. 279, no. 11, pp. 9681–9684, 2004.
[192] A. Carr´ e, G. Szinnai, M. Castanet et al., “Five new
TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome:
rescue by PAX8 synergism in one case,” Human Molecular
Genetics, vol. 18, no. 12, pp. 2266–2276, 2009.
[193] L. Guillot, A. Carr´ e, G. Szinnai et al., “NKX2-1 mutations
leading to surfactant protein promoter dysregulation cause
interstitial lung disease in ‘brain-lung-thyroid syndrome’,”
Human Mutation, vol. 31, no. 2, pp. E1146–E1162, 2010.
[194] G. Kleiner-Fisman, E. Rogaeva, W. Halliday et al., “Benign
hereditary chorea: clinical, genetic, and pathological ﬁnd-
ings,” Annals of Neurology, vol. 54, no. 2, pp. 244–247, 2003.
[195] G.Kleiner-FismanandA.E.Lang,“Benignhereditarychorea
revisited: a journey to understanding,” Movement Disorders,
vol. 22, no. 16, pp. 2297–2305, 2007.Neural Plasticity 21
[196] M. I. Morasso and N. Radoja, “Dlx genes, p63, and ectoder-
mal dysplasias,” Birth Defects Research C,v o l .7 5 ,n o .3 ,p p .
163–171, 2005.
[197] N. L. Iacono, S. Mantero, A. Chiarelli et al., “Regulation of
Dlx5 and Dlx6 gene expression by p63 is involved in EEC and
SHFM congenital limb defects,” Development, vol. 135, no. 7,
pp. 1377–1388, 2008.
[198] A. Tagariello, R. Heller, A. Greven et al., “Balanced translo-
cation in a patient with craniosynostosis disrupts the
SOX6 gene and an evolutionarily conserved non-transcribed
region,” Journal of Medical Genetics, vol. 43, no. 6, pp. 534–
540, 2006.
[199] F. H. Yu, M. Mantegazza, R. E. Westenbroek et al., “Reduced
sodium current in GABAergic interneurons in a mouse
model of severe myoclonic epilepsy in infancy,” Nature
Neuroscience, vol. 9, no. 9, pp. 1142–1149, 2006.
[200] M. S. Martin, K. Dutt, L. A. Papale et al., “Altered function
of the SCN1A voltage-gated sodium channel leads to γ-
aminobutyric acid-ergic (GABAergic) interneuron abnor-
malities,” Journal of Biological Chemistry, vol. 285, no. 13, pp.
9823–9834, 2010.
[201] G. Friocourt, S. Kanatani, H. Tabata et al., “Cell-autonomous
roles of ARX in cell proliferation and neuronal migration
during corticogenesis,” The Journal of Neuroscience, vol. 28,
no. 22, pp. 5794–5805, 2008.
[202] G. Friocourt, K. Poirier, S. Raki´ c, J. G. Parnavelas, and J.
Chelly, “The role of ARX in cortical development,” European
Journal of Neuroscience, vol. 23, no. 4, pp. 869–876, 2006.
[203] G. Friocourt and J. G. Parnavelas, “Mutations in ARX result
in several defects involving GABAergic neurons,” Frontiers in
Cellular Neuroscience, vol. 4, article 4, 2010.
[204] K.Poirier,H.vanEsch,G.Friocourtetal.,“Neuroanatomical
distribution of ARX in brain and its localisation in GABAer-
gic neurons,” Molecular Brain Research, vol. 122, no. 1, pp.
35–46, 2004.
[205] G. Colasante, P. Collombat, V. Raimondi et al., “Arx is a
directtargetofDlx2andtherebycontributestothetangential
migration of GABAergic interneurons,” The Journal of Neu-
roscience, vol. 28, no. 42, pp. 10674–10686, 2008.
[206] M. G. Price, J. W. Yoo, D. L. Burgess et al., “A triplet
repeat expansion genetic mouse model of infantile spasms
syndrome, Arx
(GCG)10+7, with interneuronopathy, spasms in
infancy, persistent seizures, and adult cognitive and behav-
ioral impairment,” The Journal of Neuroscience, vol. 29, no.
27, pp. 8752–8763, 2009.
[207] E. Marsh, C. Fulp, E. Gomez et al., “Targeted loss of
Arx results in a developmental epilepsy mouse model and
recapitulatesthehumanphenotypeinheterozygousfemales,”
Brain, vol. 132, no. 6, pp. 1563–1576, 2009.
[208] F. Mari, S. Azimonti, I. Bertani et al., “CDKL5 belongs to
the same molecular pathway of MeCP2 and it is responsible
for the early-onset seizure variant of Rett syndrome,” Human
Molecular Genetics, vol. 14, no. 14, pp. 1935–1946, 2005.
[209] I. Bertani, L. Rusconi, F. Bolognese et al., “Functional
consequences of mutations in CDKL5, an X-linked gene
involved in infantile spasms and mental retardation,” Journal
of Biological Chemistry, vol. 281, no. 42, pp. 32048–32056,
2006.
[210] X. Nan, H. H. Ng, C. A. Johnson et al., “Transcriptional
repression by the methyl-CpG-binding protein MeCP2
involves a histone deacetylase complex,” Nature, vol. 393, no.
6683, pp. 386–389, 1998.
[211] X. Nan and A. Bird, “The biological functions of the methyl-
CpG-binding protein MeCP2 and its implication in Rett
syndrome,” Brain and Development, vol. 23, no. 1, pp. S32–
S37, 2001.
[212] J. L. Noebels and R. L. Sidman, “Inherited epilepsy: spike-
wave and focal motor seizures in the mutant mouse totter-
ing,” Science, vol. 204, no. 4399, pp. 1334–1336, 1979.
[213] C. F. Fletcher, C. M. Lutz, T. N. O’Sullivan et al., “Absence
epilepsy in tottering mutant mice is associated with calcium
channel defects,” Cell, vol. 87, no. 4, pp. 607–617, 1996.
[214] Y. Zhang, M. Mori, D. L. Burgess, and J. L. Noebels,
“Mutations in high-voltage-activated calcium channel genes
stimulate low-voltage-activated currents in mouse thalamic
relay neurons,” The Journal of Neuroscience, vol. 22, no. 15,
pp. 6362–6371, 2002.
[215] E. Tsakiridou, L. Bertollini, M. de Curtis, G. Avanzini, and H.
C. Pape, “Selective increase in T-type calcium conductance
of reticular thalamic neurons in a rat model of absence
epilepsy,”TheJournalofNeuroscience,vol.15,no.4,pp.3110–
3117, 1995.
[216] D. L. Burgess, J. M. Jones, M. H. Meisler, and J. L. Noebels,
“Mutation of the Ca2+ channel β subunit gene Cchb4 is
associated with ataxia and seizures in the lethargic (lh)
mouse,” Cell, vol. 88, no. 3, pp. 385–392, 1997.
[217] D. W. Cope, G. Di Giovanni, S. J. Fyson et al., “Enhanced
tonic GABAA inhibition in typical absence epilepsy,” Nature
Medicine, vol. 15, pp. 1392–1398, 2009.
[218] S. A. Anderson, D. D. Eisenstat, L. Shi, and J. L. R.
Rubenstein, “Interneuron migration from basal forebrain to
neocortex: dependence on Dlx genes,” Science, vol. 278, no.
5337, pp. 474–476, 1997.
[219] A. Bulfone, F. Wang, R. Hevner et al., “An olfactory sensory
mapdevelopsintheabsenceofnormalprojectionneuronsor
GABAergic interneurons,” Neuron, vol. 21, no. 6, pp. 1273–
1282, 1998.
[220] I. Cobos, U. Borello, and J. L. R. Rubenstein, “Dlx transcrip-
tion factors promote migration through repression of axon
and dendrite growth,” Neuron, vol. 54, no. 6, pp. 873–888,
2007.
[221] I. Cobos, M. E. Calcagnotto, A. J. Vilaythong et al., “Mice
lacking Dlx1 show subtype-speciﬁc loss of interneurons,
reduced inhibition and epilepsy,” Nature Neuroscience, vol. 8,
no. 8, pp. 1059–1068, 2005.
[222] L. Sussel, O. Marin, S. Kimura, and J. L. R. Rubenstein,
“Loss of Nkx2.1 homeobox gene function results in a
ventral to dorsal molecular respeciﬁcation within the basal
telencephalon: evidence for a transformation of the pallidum
into the striatum,” Development, vol. 126, no. 15, pp. 3359–
3370, 1999.
[223] E. Azim, D. Jabaudon, R. M. Fame, and J. D. MacKlis, “SOX6
controls dorsal progenitor identity and interneuron diversity
during neocortical development,” Nature Neuroscience, vol.
12, no. 10, pp. 1238–1247, 2009.
[224] M.LeBon-JegoandR.Yuste,“Persistentlyactive,pacemaker-
like neurons in neocortex,” Frontiers in Neuroscience, vol. 1,
no. 1, pp. 123–129, 2007.
[225] X. Xu, K. D. Roby, and E. M. Callaway, “Mouse cortical
inhibitory neuron type that coexpresses somatostatin and
calretinin,” Journal of Comparative Neurology, vol. 499, no.
1, pp. 144–160, 2006.
[226] X. Xu, K. D. Roby, and E. M. Callaway, “Immunochemical
characterization of inhibitory mouse cortical neurons: three
chemically distinct classes of inhibitory cells,” Journal of
Comparative Neurology, vol. 518, no. 3, pp. 389–404, 2010.
[227] J. T. Porter, B. Cauli, J. F. Staiger, B. Lambolez, J. Rossier, and
E. Audinat, “Properties of bipolar VIPergic interneurons and22 Neural Plasticity
their excitation by pyramidal neurons in the rat neocortex,”
European Journal of Neuroscience, vol. 10, no. 12, pp. 3617–
3628, 1998.
[228] L. Acs´ ady, D. Arabadzisz, and T. F. Freund, “Correlated
morphological and neurochemical features identify diﬀerent
subsets of vasoactive intestinal polypeptide-immunoreactive
interneurons in rat hippocampus,” Neuroscience, vol. 73, no.
2, pp. 299–315, 1996.
[229] N. Hajos, L. Acsady, and T. F. Freund, “Target selectivity
and neurochemical characteristics of VIP-immunoreactive
interneurons in the rat dentate gyrus,” European Journal of
Neuroscience, vol. 8, no. 7, pp. 1415–1431, 1996.
[230] C. D´ avid, A. Schleicher, W. Zuschratter, and J. F. Staiger,
“The innervation of parvalbumin-containing interneu-
rons by VIP-immunopositive interneurons in the primary
somatosensory cortex of the adult rat,” European Journal of
Neuroscience, vol. 25, no. 8, pp. 2329–2340, 2007.
[231] X. Xu and E. M. Callaway, “Laminar speciﬁcity of functional
input to distinct types of inhibitory cortical neurons,” The
Journal of Neuroscience, vol. 29, no. 1, pp. 70–85, 2009.
[232] A. Karagiannis, T. Gallopin, C. D´ avid et al., “Classiﬁcation
of NPY-expressing neocortical interneurons,” The Journal of
Neuroscience, vol. 29, no. 11, pp. 3642–3659, 2009.
[233] S. Olah, G. Komlosi, J. Szabadics et al., “Output of neurogli-
aform cells to various neuron types in the human and rat
cerebral cortex,” Frontiers in Neural Circuits, vol. 1, article 4,
2007.
[234] G. Tam´ a s ,A .L¨ orincz, A. Simon, and J. Szabadics, “Identiﬁed
sources and targets of slow inhibition in the neocortex,”
Science, vol. 299, no. 5614, pp. 1902–1905, 2003.
[235] S. Olah, M. Fule, G. Komlosi et al., “Regulation of cortical
microcircuits by unitary GABA-mediated volume transmis-
sion,” Nature, vol. 461, no. 7268, pp. 1278–1281, 2009.
[236] G. Biagini, G. Panuccio, and M. Avoli, “Neurosteroids and
epilepsy,” Current Opinion in Neurology,v o l .2 3 ,n o .2 ,p p .
170–176, 2010.
[237] J. M. Pellock, R. Hrachovy, S. Shinnar et al., “Infantile
spasms: a U.S. consensus report,” Epilepsia, vol. 51, no. 10,
pp. 2175–2189, 2010.
[238] C. J. Price, B. Cauli, E. R. Kovacs et al., “Neurogliaform
neuronsformanovelinhibitorynetworkinthehippocampal
CA1 area,” The Journal of Neuroscience, vol. 25, no. 29, pp.
6775–6786, 2005.
[239] A. Simon, S. Olah, G. Molnar, J. Szabadics, and G. Tamas,
“Gap-junctional coupling between neurogliaform cells and
various interneuron types in the neocortex,” The Journal of
Neuroscience, vol. 25, no. 27, pp. 6278–6285, 2005.
[240] V. Zsiros and G. Maccaferri, “Electrical coupling between
interneurons with diﬀerent excitable properties in the stra-
tum lacunosum-moleculare of the juvenile CA1 rat hip-
pocampus,” The Journal of Neuroscience, vol. 25, no. 38, pp.
8686–8695, 2005.
[241] B. Cauli, X. K. Tong, A. Rancillac et al., “Cortical GABA
interneurons in neurovascular coupling: relays for subcorti-
cal vasoactive pathways,” The Journal of Neuroscience, vol. 24,
no. 41, pp. 8940–8949, 2004.
[242] B. Cauli and E. Hamel, “Revisiting the role of neurons in
neurovascular coupling,” Frontiers in Neuroenergetics, vol. 2,
article 9, 2010.
[243] S. Anderson, M. Mione, K. Yun, and J. L. R. Rubenstein,
“Diﬀerential origins of neocortical projection and local
circuit neurons: role of Dlx genes in neocortical interneu-
ronogenesis,” Cerebral Cortex, vol. 9, no. 6, pp. 646–654,
1999.
[244] S. A. Anderson, O. Mar´ ın, C. Horn, K. Jennings, and J. L.
R. Rubenstein, “Distinct cortical migrations from the medial
and lateral ganglionic eminences,” Development, vol. 128, no.
3, pp. 353–363, 2001.
[245] J. G. Corbin, S. Nery, and G. Fishell, “Telencephalic cells
take a tangent: non-radial migration in the mammalian
forebrain,” Nature Neuroscience, vol. 4, no. 1, pp. 1177–1182,
2001.
[246] G. Miyoshi and G. Fishell, “GABAergic interneuron lineages
selectively sort into speciﬁc cortical layers during early
postnatal development,” Cerebral Cortex,v o l .2 1 ,n o .4 ,p p .
845–852, 2011.
[247] M.H.Porteus,A.Bulfone,J.K.Liu,L.Puelles,L.C.Lo,andJ.
L. R. Rubenstein, “DLX-2, MASH-1, and MAP-2 expression
and bromodeoxyuridine incorporation deﬁne molecularly
distinct cell populations in the embryonic mouse forebrain,”
The Journal of Neuroscience, vol. 14, no. 11, pp. 6370–6383,
1994.
[248] S. J. Pleasure, S. Anderson, R. Hevner et al., “Cell migration
from the ganglionic eminences is required for the develop-
mentofhippocampalGABAergicinterneurons,”Neuron,vol.
28, no. 3, pp. 727–740, 2000.
[249] M.Kohwi,M.A.Petryniak,J.E.Longetal.,“Asubpopulation
of olfactory bulb GABAergic interneurons is derived from
Emx1-a n dDlx5/6-expressing progenitors,” The Journal of
Neuroscience, vol. 27, no. 26, pp. 6878–6891, 2007.
[250] S. Casarosa, C. Fode, and F. Guillemot, “Mash1 regulates
neurogenesis in theventral telencephalon,”Development,vol.
126, no. 3, pp. 525–534, 1999.
[251] M. Fogarty, M. Grist, D. Gelman, O. Mar´ ın, V. Pachnis, and
N. Kessaris, “Spatial genetic patterning of the embryonic
neuroepithelium generates GABAergic interneuron diversity
in the adult cortex,” The Journal of Neuroscience, vol. 27, no.
41, pp. 10935–10946, 2007.
[252] C. P. Wonders, L. Taylor, J. Welagen, I. C. Mbata, J. Z.
Xiang, and S. A. Anderson, “A spatial bias for the origins
of interneuron subgroups within the medial ganglionic
eminence,” Developmental Biology, vol. 314, no. 1, pp. 127–
136, 2008.
[253] N. Flames, R. Pla, D. M. Gelman, J. L. R. Rubenstein, L.
Puelles, and O. Mar´ ın, “Delineation of multiple subpallial
progenitor domains by the combinatorial expression of
transcriptional codes,” The Journal of Neuroscience, vol. 27,
no. 36, pp. 9682–9695, 2007.
[254] Q. Xu, L. Guo, H. Moore, R. R. Waclaw, K. Campbell, and
S. A. Anderson, “Sonic hedgehog signaling confers ventral
telencephalic progenitors with distinct cortical interneuron
fates,” Neuron, vol. 65, no. 3, pp. 328–340, 2010.
[255] V. H. Sousa, G. Miyoshi, J. Hjerling-Leﬄer, T. Karayan-
nis, and G. Fishell, “Characterization of Nkx6-2-derived
neocortical interneuron lineages,” Cerebral Cortex, vol. 19,
supplement 1, pp. i1–i10, 2009.
[256] M. Grigoriou, A. S. Tucker, P. T. Sharpe, and V. Pachnis,
“Expression and regulation of Lhx6 and Lhx7, a novel
subfamily of LIM homeodomain encoding genes, suggests
a role in mammalian head development,” Development, vol.
125, no. 11, pp. 2063–2074, 1998.
[257] P. Liodis, M. Denaxa, M. Grigoriou, C. Akufo-Addo, Y.
Yanagawa, and V. Pachnis, “Lhx6 activity is required for the
normal migration and speciﬁcation of cortical interneuron
subtypes,” The Journal of Neuroscience, vol. 27, no. 12, pp.
3078–3089, 2007.
[258] Y. Zhao, P. Flandin, J. E. Long, M. D. Cuesta, H. Westphal,
and J. L. R. Rubenstein, “Distinct molecular pathways ofNeural Plasticity 23
development of telencephalic interneuron subtypes revealed
through analysis of Lhx6 mutants,” Journal of Comparative
Neurology, vol. 510, no. 1, pp. 79–99, 2008.
[259] M. And¨ ang, J. Hjerling-Leﬄer, A. Moliner et al., “Histone
H2AX-dependent GABAA receptor regulation of stem cell
proliferation,” Nature, vol. 451, no. 7177, pp. 460–464, 2008.
[260] J. J. LoTurco, D. F. Owens, M. J. S. Heath, M. B. E. Davis, and
A. R. Kriegstein, “GABA and glutamate depolarize cortical
progenitor cells and inhibit DNA synthesis,” Neuron, vol. 15,
no. 6, pp. 1287–1298, 1995.
[261] N. Heck, W. Kilb, P. Reiprich et al., “GABA-A receptors
regulate neocortical neuronal migration in vitro and in vivo,”
Cerebral Cortex, vol. 17, no. 1, pp. 138–148, 2007.
[262] R. Tyzio, A. Represa, I. Jorquera, Y. Ben-Ari, H. Gozlan, and
L. Aniksztejn, “The establishment of GABAergic and gluta-
matergic synapses on CA1 pyramidal neurons is sequential
and correlates with the development of the apical dendrite,”
The Journal of Neuroscience, vol. 19, no. 23, pp. 10372–10382,
1999.
[263] S. Hennou, I. Khalilov, D. Diabira, Y. Ben-Ari, and H.
Gozlan, “Early sequential formation of functional GABAA
and glutamatergic synapses on CA1 interneurons of the rat
foetal hippocampus,” European Journal of Neuroscience, vol.
16, no. 2, pp. 197–208, 2002.
[264] E. Delpire, “Cation-chloride cotransporters in neuronal
communication,” News in Physiological Sciences, vol. 15, no.
6, pp. 309–312, 2000.
[265] C. Rivera, J. Voipio, J. A. Payne et al., “The K+/Cl− co-
transporter KCC2 renders GABA hyperpolarizing during
neuronal maturation,” Nature, vol. 397, no. 6716, pp. 251–
255, 1999.
[266] H. Li, J. Tornberg, K. Kaila, M. S. Airaksinen, and C. Rivera,
“Patterns of cation-chloride cotransporter expression during
embryonic rodent CNS development,” European Journal of
Neuroscience, vol. 16, no. 12, pp. 2358–2370, 2002.
[267] J. B. Manent, M. Demarque, I. Jorquera et al., “A noncanon-
ical release of GABA and glutamate modulates neuronal
migration,” The Journal of Neuroscience, vol. 25, no. 19, pp.
4755–4765, 2005.
[268] D. Bortone and F. Polleux, “KCC2 expression promotes the
termination of cortical interneuron migration in a voltage-
sensitive calcium-dependent manner,” Neuron,v o l .6 2 ,n o .1 ,
pp. 53–71, 2009.
[269] D. D. Wang and A. R. Kriegstein, “GABA regulates excitatory
synapse formation in the neocortex via NMDA receptor
activation,” The Journal of Neuroscience, vol. 28, no. 21, pp.
5547–5558, 2008.
[270] D. D. Wang and A. R. Kriegstein, “Blocking early GABA
depolarization with bumetanide results in permanent alter-
ations in cortical circuits and sensorimotor gating deﬁcits,”
Cerebral Cortex, vol. 21, no. 3, pp. 574–587, 2011.
[271] L. Cancedda, H. Fiumelli, K. Chen, and M. M. Poo, “Excita-
tory GABA action is essential for morphological maturation
of cortical neurons in vivo,” The Journal of Neuroscience, vol.
27, no. 19, pp. 5224–5235, 2007.
[272] R. Cossart, “The maturation of cortical interneuron diver-
sity: how multiple developmental journeys shape the emer-
gence of proper network function,” Current Opinion in
Neurobiology, vol. 21, no. 1, pp. 160–168, 2010.
[273] T. K. Hensch, M. Fagiolini, N. Mataga, M. P. Stryker, S.
Baekkeskov, and S. F. Kash, “Local GABA circuit control of
experience-dependent plasticity in developing visual cortex,”
Science, vol. 282, no. 5393, pp. 1504–1508, 1998.
[274] M. Fagiolini, J. M. Fritschy, K. Low, H. Mohler, U. Rudolph,
andT.K.Hensch, “Speciﬁc GABAA circuits forvisual cortical
plasticity,” Science, vol. 303, no. 5664, pp. 1681–1683, 2004.
[275] Y. Yazaki-Sugiyama, S. Kang, H. Cteau, T. Fukai, and T.
K. Hensch, “Bidirectional plasticity in fast-spiking GABA
circuits by visual experience,” Nature, vol. 462, no. 7270, pp.
218–221, 2009.
[276] A. Harauzov, M. Spolidoro, G. DiCristo et al., “Reducing
intracortical inhibition in the adult visual cortex promotes
oculardominanceplasticity,”TheJournalofNeuroscience,vol.
30, no. 1, pp. 361–371, 2010.
[277] V. Cr´ e p e l ,D .A r o n o v ,I .J o r q u e r a ,A .R e p r e s a ,Y .B e n - A r i ,a n d
R. Cossart, “A parturition-associated nonsynaptic coherent
activity pattern in the developing hippocampus,” Neuron,
vol. 54, no. 1, pp. 105–120, 2007.
[278] C. All` ene, A. Cattani, J. B. Ackman et al., “Sequential
generation of two distinct synapse-driven network patterns
indevelopingneocortex,”TheJournalofNeuroscience,vol.28,
no. 48, pp. 12851–12863, 2008.
[279] Y. Ben-Ari, E. Cherubini, R. Corradetti, and J. L. Gaiarsa,
“GiantsynapticpotentialsinimmatureratCA3hippocampal
neurones,” Journal of Physiology, vol. 416, pp. 303–325, 1989.
[280] P. Bonifazi, M. Goldin, M. A. Picardo et al., “GABAergic hub
neurons orchestrate synchrony in developing hippocampal
networks,” Science, vol. 326, no. 5958, pp. 1419–1424, 2009.
[281] M. D. Lundorf, H. N. Buttenschon, L. Foldager et al.,
“Mutational screening and association study of glutamate
decarboxylase 1 as a candidate susceptibility gene for bipolar
aﬀective disorder and schizophrenia,” American Journal of
Medical Genetics Part B, vol. 135, no. 1, pp. 94–101, 2005.
[282] R. Batista-Brito, R. MacHold, C. Klein, and G. Fishell, “Gene
expression in cortical interneuron precursors is prescient of
their mature function,” Cerebral Cortex, vol. 18, no. 10, pp.
2306–2317, 2008.
[283] J. DeFelipe, “Cortical interneurons: from Cajal to 2001,”
Progress in Brain Research, vol. 136, pp. 215–238, 2002.
[284] P. Rakic, “Evolution of the neocortex: a perspective from
developmental biology,” Nature Reviews Neuroscience, vol.
10, no. 10, pp. 724–735, 2009.
[285] J. DeFelipe, “Types of neurons, synaptic connections
and chemical characteristics of cells immunoreactive for
calbindin-D28K, parvalbumin and calretinin in the neocor-
tex,” Journal of Chemical Neuroanatomy,v o l .1 4 ,n o .1 ,p p .
1–19, 1997.
[286] J. DeFelipe, L. Alonso-Nanclares, and J. I. Arellano,
“Microstructure of the neocortex: comparative aspects,”
Journal of Neurocytology, vol. 31, no. 3–5, pp. 299–316, 2002.
[287] K. Letinic, R. Zoncu, and P. Rakic, “Origin of GABAergic
neurons in the human neocortex,” Nature, vol. 417, no. 6889,
pp. 645–649, 2002.
[288] S. Rakic and N. Zecevic, “Emerging complexity of layer I in
human cerebral cortex,” Cerebral Cortex, vol. 13, no. 10, pp.
1072–1083, 2003.
[289] X. Yu and N. Zecevic, “Dorsal radial glial cells have the
potential to generate cortical interneurons in human but not
in mouse brain,” The Journal of Neuroscience, vol. 31, no. 7,
pp. 2413–2420, 2011.
[290] S. Lindsay, S. Sarma, M. Mart´ ınez-de-la-Torre et al.,
“Anatomical and gene expression mapping of the ventral
pallium in a three-dimensional model of developing human
brain,” Neuroscience, vol. 136, no. 3, pp. 625–632, 2005.
[291] S. Sarma, J. Kerwin, L. Puelles et al., “3D modelling, gene
expression mapping and post-mapping image analysis in the24 Neural Plasticity
developinghumanbrain,”BrainResearchBulletin,vol.66,no.
4–6, pp. 449–453, 2005.
[292] I. Jakovcevski, N. Mayer, and N. Zecevic, “Multiple origins
of human neocortical interneurons are supported by distinct
expression of transcription factors,” Cerebral Cortex, vol. 21,
no. 8, pp. 1771–1782, 2011.
[293] N. Zecevic, F. Hu, and I. Jakovcevski, “Interneurons in the
developing human neocortex,” Developmental Neurobiology,
vol. 71, no. 1, pp. 18–33, 2011.
[294] DSM-IV, Diagnostic and Statistical Manual of Mental Dis-
orders, American Psychiatric Association, Washington, DC,
USA, 1994.
[295] B. Elvevag and T. E. Goldberg, “Cognitive impairment in
schizophrenia is the core of the disorder,” Critical Reviews in
Neurobiology, vol. 14, no. 1, pp. 1–21, 2000.
[296] J. R. Cohen, B. Elvev˚ ag, and T. E. Goldberg, “Cognitive con-
trolandsemanticsinschizophrenia:anintegratedapproach,”
American Journal of Psychiatry, vol. 162, no. 10, pp. 1969–
1971, 2005.
[297] Z. H. Qin, S. P. Zhang, and B. Weiss, “Dopaminergic and
glutamatergic blocking drugs diﬀerentially regulate glutamic
acid decarboxylase mRNA in mouse brain,” Molecular Brain
Research, vol. 21, no. 3-4, pp. 293–302, 1994.
[298] M. Gierdalski, B. Jablonska, A. Smith, J. Skangiel-Kramska,
and M. Kossut, “Deaﬀerentation induced changes in GAD67
and GluR2 mRNA expression in mouse somatosensory
cortex,” Molecular Brain Research, vol. 71, no. 1, pp. 111–119,
1999.
[299] R. S. Woo, X. M. Li, Y. Tao et al., “Neuregulin-1 enhances
depolarization-induced GABA release,” Neuron, vol. 54, no.
4, pp. 599–610, 2007.
[300] D. W. Volk, J. N. Pierri, J. M. Fritschy, S. Auh, A. R.
Sampson, and D. A. Lewis, “Reciprocal alterations in pre-
and postsynaptic inhibitory markers at chandelier cell inputs
to pyramidal neurons in schizophrenia,” Cerebral Cortex, vol.
12, no. 10, pp. 1063–1070, 2002.
[301] J. G. Maldonado-Avil´ es, A. A. Curley, T. Hashimoto et
al., “Altered markers of tonic inhibition in the dorsolateral
prefrontal cortex of subjects with schizophrenia,” American
Journal of Psychiatry, vol. 166, no. 4, pp. 450–459, 2009.
[302] S.R.Cobb,E.H.Buhl,K.Halasy,O.Paulsen,andP.Somogyi,
“Synchronization of neuronal activity in hippocampus by
individual GABAergic interneurons,” Nature, vol. 378, no.
6552, pp. 75–78, 1995.
[303] S. L. Smalley, P. E. Tanguay, M. Smith, and G. Gutierrez,
“Autism and tuberous sclerosis,” Journal of Autism and
Developmental Disorders, vol. 22, no. 3, pp. 339–355, 1992.
[304] S. L. Smalley, “Autism and tuberous sclerosis,” Journal of
Autism and Developmental Disorders, vol. 28, no. 5, pp. 407–
414, 1998.
[305] J. Sebat, B. Lakshmi, D. Malhotra et al., “Strong association
ofdenovocopynumbermutationswithautism,”Science,vol.
316, no. 5823, pp. 445–449, 2007.
[306] R. A. Kumar, S. Karamohamed, J. Sudi et al., “Recurrent
16p11.2 microdeletions in autism,” Human Molecular Genet-
ics, vol. 17, no. 4, pp. 628–638, 2008.
[307] C. R. Marshall, A. Noor, J. B. Vincent et al., “Structural
variation of chromosomes in autism spectrum disorder,”
American Journal of Human Genetics, vol. 82, no. 2, pp. 477–
488, 2008.
[308] L. A. Weiss, Y. Shen, J. M. Korn et al., “Association between
microdeletion and microduplication at 16p11.2 and autism,”
TheNewEnglandJournalofMedicine,vol.358,no.7,pp.667–
675, 2008.
[309] M. W. State, “The genetics of child psychiatric disorders:
focus on autism and tourette syndrome,” Neuron, vol. 68, no.
2, pp. 254–269, 2010.
[310] S. Lim, S. Naisbitt, J. Yoon et al., “Characterization of
the Shank family of synaptic proteins: multiple genes,
alternative splicing, and diﬀerential expression in brain and
development,” Journal of Biological Chemistry, vol. 274, no.
41, pp. 29510–29518, 1999.
[311] A. A. Chubykin, X. Liu, D. Comoletti, I. Tsigelny, P. Taylor,
a n dT .C .S ¨ udhof, “Dissection of synapse induction by
neuroligins: eﬀect of a neuroligin mutation associated with
autism,” Journal of Biological Chemistry, vol. 280, no. 23, pp.
22365–22374, 2005.
[312] G. D¨ olen, R. L. Carpenter, T. D. Ocain, and M. F. Bear,
“Mechanism-based approaches to treating fragile X,” Phar-
macology and Therapeutics, vol. 127, no. 1, pp. 78–93, 2010.
[313] A. Brooks-Kayal, “Epilepsy and autism spectrum disorders:
are there common developmental mechanisms?” Brain and
Development, vol. 32, no. 9, pp. 731–738, 2010.
[314] A. Yasuhara, “Correlation between EEG abnormalities and
symptoms of autism spectrum disorder (ASD),” Brain and
Development, vol. 32, no. 10, pp. 791–798, 2010.
[315] N. C. de Lanerolle, J. H. Kim, R. J. Robbins, and D. D.
Spencer, “Hippocampal interneuron loss and plasticity in
human temporal lobe epilepsy,” Brain Research, vol. 495, no.
2, pp. 387–395, 1989.
[316] P. Marco, R. G. Sola, P. Pulido et al., “Inhibitory neurons in
the human epileptogenic temporal neocortex: an immuno-
cytochemical study,” Brain, vol. 119, no. 4, pp. 1327–1347,
1996.
[317] L. Wittner, Z. Magloczky, Z. Borhegyi et al., “Preservation of
perisomatic inhibitory input of granule cells in the epileptic
human dentate gyrus,” Neuroscience, vol. 108, no. 4, pp. 587–
600, 2001.
[318] L. A. Jansen, L. D. Peugh, and J. G. Ojemann, “GABAA recep-
tor properties in catastrophic infantile epilepsy,” Epilepsy
Research, vol. 81, no. 2-3, pp. 188–197, 2008.
[319] I. Cohen, V. Navarro, S. Clemenceau, M. Baulac, and R.
Miles,“Ontheoriginofinterictalactivityinhumantemporal
lobe epilepsy in vitro,” Science, vol. 298, no. 5597, pp. 1418–
1421, 2002.
[320] I.Khalilov,G.L.Holmes,andY.Ben-Ari,“Invitroformation
of a secondary epileptogenic mirror focus by interhippocam-
pal propagation of seizures,” Nature Neuroscience, vol. 6, no.
10, pp. 1079–1085, 2003.
[321] R. S. Sloviter, “Decreased hippocampal inhibition and a
selective loss of interneurons in experimental epilepsy,”
Science, vol. 235, no. 4784, pp. 73–76, 1987.
[322] R. S. Sloviter, “Permanently altered hippocampal structure,
excitability, and inhibition after experimental status epilep-
ticus in the rat: the “dormant basket cell” hypothesis and its
possible relevance to temporal lobe epilepsy,” Hippocampus,
vol. 1, no. 1, pp. 41–66, 1991.
[323] D. H. Lowenstein, M. J. Thomas, D. H. Smith, and T. K.
McIntosh, “Selective vulnerability of dentate hilar neurons
followingtraumaticbraininjury:apotentialmechanisticlink
between head trauma and disorders of the hippocampus,”
The Journal of Neuroscience, vol. 12, no. 12, pp. 4846–4853,
1992.
[324] P. S. Buckmaster and A. L. Jongen-Rˆ elo, “Highly speciﬁc
neuron loss preserves lateral inhibitory circuits in the dentate
gyrus of kainate-induced epileptic rats,” The Journal of
Neuroscience, vol. 19, no. 21, pp. 9519–9529, 1999.Neural Plasticity 25
[325] C. Dinocourt, Z. Petanjek, T. F. Freund, Y. Ben-Ari, and M.
Esclapez, “Loss of interneurons innervating pyramidal cell
dendrites and axon initial segments in the CA1 region of
the hippocampus following pilocarpine-induced seizures,”
Journal of Comparative Neurology, vol. 459, no. 4, pp. 407–
425, 2003.
[326] N. C. de Lanerolle, J. H. Kim, A. Williamson et al., “A ret-
rospective analysis of hippocampal pathology in human
temporal lobe epilepsy: evidence for distinctive patient
subcategories,” Epilepsia, vol. 44, no. 5, pp. 677–687, 2003.
[327] A. Andrioli, L. Alonso-Nanclares, J. I. Arellano, and J. DeFe-
lipe, “Quantitative analysis of parvalbumin-immunoreactive
cellsinthehumanepileptichippocampus,”Neuroscience,vol.
149, no. 1, pp. 131–143, 2007.
[328] J. DeFelipe, “Chandelier cells and epilepsy,” Brain, vol. 122,
no. 10, pp. 1807–1822, 1999.
[329] J. I. Arellano, A. Mu˜ noz, I. Ballesteros-Y´ a˜ nez, R. G. Sola,
andJ.DeFelipe,“Histopathologyandreorganizationofchan-
delier cells in the human epileptic sclerotic hippocampus,”
Brain, vol. 127, no. 1, pp. 45–64, 2004.
[330] U. Sayin, S. Osting, J. Hagen, P. Rutecki, and T. Sutula,
“Spontaneous seizures and loss of axo-axonic and axo-
somatic inhibition induced by repeated brief seizures in
kindled rats,” The Journal of Neuroscience, vol. 23, no. 7, pp.
2759–2768, 2003.
[331] E. A. van Vliet, E. Aronica, E. A. Tolner, F. H. Lopes da
Silva, and J. A. Gorter, “Progression of temporal lobe
epilepsy in the rat is associated with immunocytochemical
changes in inhibitory interneurons in speciﬁc regions of the
hippocampal formation,” Experimental Neurology, vol. 187,
no. 2, pp. 367–379, 2004.
[332] L. Palm, G. Blennow, and A. Brun, “Infantile spasms and
neuronal heterotopias: a report on six cases,” Acta Paediatrica
Scandinavica, vol. 75, no. 5, pp. 855–859, 1986.
[333] K. Jellinger, “Neuropathological aspects of infantile spasms,”
Brain and Development, vol. 9, no. 4, pp. 349–357, 1987.
[334] H. V. Vinters, M. J. de Rosa, M. A. Farrell, P. Genton, A.
Portera-Sanchez, and C. K. Benninger, “Neuropathologic
study of resected cerebral tissue from patients with infantile
spasms,” Epilepsia, vol. 34, no. 4, pp. 772–779, 1993.
[335] M. Hayashi, “Neuropathology of the limbic system and
brainstem in West syndrome,” Brain and Development, vol.
23, no. 7, pp. 516–522, 2001.
[336] R. Riikonen, “Long-term outcome of patients with West
syndrome,” Brain and Development, vol. 23, no. 7, pp. 683–
687, 2001.
[337] L. A. Jansen, L. D. Peugh, W. H. Roden, and J. G. Ojemann,
“ImpairedmaturationofcorticalGABAA receptorexpression
in pediatric epilepsy,” Epilepsia, vol. 51, no. 8, pp. 1456–1467,
2010.
[338] L. Claes, B. Ceulemans, D. Audenaert et al., “De novo SCN1A
mutations are a major cause of severe myoclonic epilepsy of
infancy,” Human Mutation, vol. 21, no. 6, pp. 615–621, 2003.
[339] K. Kanai, S. Hirose, H. Oguni et al., “Eﬀect of localization
of missense mutations in SCN1A on epilepsy phenotype
severity,” Neurology, vol. 63, no. 2, pp. 329–334, 2004.
[340] K. Kanai, S. Yoshida, S. Hirose et al., “Physicochemical
property changes of amino acid residues that accompany
missense mutations in SCN1A aﬀect epilepsy phenotype
severity,” Journal of Medical Genetics, vol. 46, no. 10, pp. 671–
679, 2009.
[341] I. Ogiwara, H. Miyamoto, N. Morita et al., “NaV1.1 localizes
to axons of parvalbumin-positive inhibitory interneurons: a
circuit basis for epileptic seizures in mice carrying an Scn1a
gene mutation,” The Journal of Neuroscience, vol. 27, no. 22,
pp. 5903–5914, 2007.
[342] E. H. Sherr, “The ARX story (epilepsy, mental retardation,
autism, and cerebral malformations): onegene leads to many
phenotypes,” Current Opinion in Pediatrics, vol. 15, no. 6, pp.
567–571, 2003.
[343] L. Rusconi, L. Salvatoni, L. Giudici et al., “CDKL5 expression
is modulated during neuronal development and its subcel-
lular distribution is tightly regulated by the C-terminal tail,”
Journal of Biological Chemistry, vol. 283, no. 44, pp. 30101–
30111, 2008.
[344] L. M. Dibbens, H. J. Feng, M. C. Richards et al., “GABRD
encoding a protein for extra- or peri- synaptic GABAA
receptors is susceptibility locus for generalized epilepsies,”
Human Molecular Genetics, vol. 13, no. 13, pp. 1315–1319,
2004.
[345] Y. Chen, J. Lu, H. Pan et al., “Association between genetic
variation of CACNA1H and childhood absence epilepsy,”
Annals of Neurology, vol. 54, no. 2, pp. 239–243, 2003.
[346] D. L. Burgess and J. L. Noebels, “Single gene defects in mice:
the role of voltage-dependent calcium channels in absence
models,” Epilepsy Research, vol. 36, no. 2-3, pp. 111–122,
1999.
[347] E. M. Talley, G. Sol´ orzano, A. Depaulis, E. Perez-Reyes,
and D. A. Bayliss, “Low-voltage-activated calcium channel
subunit expression in a genetic model of absence epilepsy in
therat,” MolecularBrainResearch,vol.75,no.1,pp.159–165,
2000.
[348] P. Smits, P. Li, J. Mandel et al., “The transcription factors
L-Sox5 and Sox6 are essential for cartilage formation,”
Developmental Cell, vol. 1, no. 2, pp. 277–290, 2001.
[349] P. Smits and V. Lefebvre, “Sox5 and Sox6 are required for
notochord extracellular matrix sheath formation, notochord
cell survival and development of the nucleus pulposus of
intervertebral discs,” Development, vol. 130, no. 6, pp. 1135–
1148, 2003.
[350] P. Smits, P. Dy, S. Mitra, and V. Lefebvre, “Sox5 and Sox6
are needed to develop and maintain source, columnar, and
hypertrophic chondrocytes in the cartilage growth plate,”
Journal of Cell Biology, vol. 164, no. 5, pp. 747–758, 2004.
[351] S. C. Baraban, D. G. Southwell, R. C. Estrada et al., “Reduc-
tion of seizures by transplantation of cortical GABAergic
interneuron precursors into Kv1.1 mutant mice,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 106, no. 36, pp. 15472–15477, 2009.
[352] J.Y.SebeandS.C.Baraban,“Thepromiseofaninterneuron-
based cell therapy for epilepsy,” Developmental Neurobiology,
vol. 71, no. 1, pp. 107–117, 2011.